{"meta":{"query_hash":"71224093593c","filters":{"venue":"Biologicals"},"cohort_total":83,"direct_labels_cover":0,"predictions_cover":83,"exported":83,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/71224093593c","api":"https://metacan.xera.ac/api/v1/cohort?venue=Biologicals"},"results":[{"id":"W1177880600","doi":"10.1016/j.biologicals.2015.07.009","title":"Report of the international conference on regulatory endeavors towards the sound development of human cell therapy products","year":2015,"lang":"en","type":"article","venue":"Biologicals","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"Medical Research Council; National Institute of Biomedical Innovation; Ministry of Health, Labour and Welfare; Japan Science and Technology Agency; World Health Organization","keywords":"Risk analysis (engineering); Process (computing); Business; Engineering ethics; Management science; Process management; Computer science; Engineering","score_opus":0.2645227128454013,"score_gpt":0.36872885893575885,"score_spread":0.10420614609035755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1177880600","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01592634,0.03656218,0.012657426,0.62689036,0.12909488,0.0029883527,0.0030569679,0.00034303006,0.17248039],"genre_scores_gemma":[0.100467116,0.028397895,0.03070464,0.39122814,0.03978515,0.0045467494,0.0044567324,0.0006710188,0.3997425],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.97251433,0.004705905,0.0017537563,0.0015738946,0.014754778,0.004697451],"domain_scores_gemma":[0.96794206,0.013394228,0.0019867138,0.0012974116,0.009302784,0.00607675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.049234834,0.0025270972,0.0016211871,0.0028938157,0.0070671407,0.014295251,0.0036416627,0.04383657,0.010151952],"category_scores_gemma":[0.03258607,0.00095283205,0.0035736486,0.0018383545,0.0045797233,0.0053078253,0.0066651106,0.03565118,0.0027106663],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039829104,0.0010729749,0.0016221636,0.0009623658,0.00011553132,0.0010260709,0.0015551073,0.0013389981,0.006687719,0.06573323,0.8910083,0.02847925],"study_design_scores_gemma":[0.00010298224,0.00014821693,0.0036845875,0.00050845824,0.00010619107,0.0001864291,0.0008062394,0.00047216448,0.0045202305,0.006374708,0.98299825,0.00009169166],"about_ca_topic_score_codex":0.020888336,"about_ca_topic_score_gemma":0.029245118,"teacher_disagreement_score":0.049234834,"about_ca_system_score_codex":0.0077421768,"about_ca_system_score_gemma":0.05979067,"threshold_uncertainty_score":0.26038182},"labels":[],"label_agreement":null},{"id":"W1966368702","doi":"10.1016/j.biologicals.2006.03.001","title":"Regulation and standardization of IPV and IPV combination vaccines","year":2006,"lang":"en","type":"article","venue":"Biologicals","topic":"Viral Infections and Immunology Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Standardization; Immunogenicity; Potency; In vivo; In vitro toxicology; Medicine; Biology; Biotechnology; Antigen; Immunology; In vitro; Computer science","score_opus":0.019687646091801386,"score_gpt":0.30678527869203787,"score_spread":0.28709763260023646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966368702","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24179766,0.04236187,0.50949335,0.021322576,0.0034787126,0.0037564004,0.002713563,0.0014612207,0.17361464],"genre_scores_gemma":[0.70530224,0.020317962,0.23972489,0.0044896808,0.0016482702,0.0040475815,0.0053265663,0.00035790453,0.018784888],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97382665,0.010163078,0.003061547,0.0017297897,0.009739565,0.0014794236],"domain_scores_gemma":[0.983214,0.0034061014,0.0030061547,0.0042720246,0.0056302575,0.00047143231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.028351488,0.0007150345,0.00069626054,0.0034401598,0.0009347955,0.0032220138,0.0025970293,0.002237537,0.0016059215],"category_scores_gemma":[0.016754402,0.00055260054,0.00072386174,0.0019963982,0.0028032546,0.0013867577,0.0018299739,0.0028325338,0.0010218376],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006711031,0.001069157,0.012349463,0.0010663013,0.00012031228,0.00022482546,0.0010994712,0.011484331,0.28573474,0.17714022,0.014874164,0.49416587],"study_design_scores_gemma":[0.00015994077,0.0034160467,0.031293135,0.0012724726,0.00024976095,0.0009920049,0.0009610986,0.0074004503,0.4450293,0.0374227,0.47168794,0.00011507606],"about_ca_topic_score_codex":0.0025763125,"about_ca_topic_score_gemma":0.0020050986,"teacher_disagreement_score":0.028351488,"about_ca_system_score_codex":0.0031202012,"about_ca_system_score_gemma":0.005797489,"threshold_uncertainty_score":0.14993876},"labels":[],"label_agreement":null},{"id":"W1968444923","doi":"10.1016/j.biologicals.2010.07.005","title":"Excipient exchange in the comparison of preparations of the same biologic made by different manufacturing processes: An exploratory study with recombinant human growth hormone (rhGH)","year":2010,"lang":"en","type":"article","venue":"Biologicals","topic":"Protein purification and stability","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"Health Canada","keywords":"Excipient; Chemistry; Innovator; Drug; Human growth hormone; Mannitol; Pharmacology; Chromatography; Biochemical engineering; Biochemistry; Hormone; Growth hormone; Medicine; Business; Entrepreneurship; Engineering","score_opus":0.03874264423928938,"score_gpt":0.30944956827301373,"score_spread":0.27070692403372437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968444923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99639624,0.00067450333,0.0025819244,0.000018776118,0.000013469112,0.000029909532,0.00004924091,0.000013081643,0.00022277352],"genre_scores_gemma":[0.9902463,0.00087699783,0.007247166,0.000042744254,0.000013294429,0.000038778446,0.00027668296,0.00007165186,0.0011863551],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99892944,0.00044414238,0.000095397976,0.00019405603,0.0002544572,0.00008244873],"domain_scores_gemma":[0.99857676,0.0007847944,0.0002308559,0.00016611093,0.00018466375,0.000056905752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016299116,0.0003186733,0.00042666539,0.0004128977,0.00039780865,0.0007483292,0.00034078248,0.0006745562,0.0005522949],"category_scores_gemma":[0.0026439843,0.00017462873,0.00046594575,0.0005966372,0.00053888245,0.00053341617,0.00037235412,0.0003884144,0.0002025166],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013724125,0.00009528852,0.0010846737,0.000062403,0.00002112753,0.00006059547,0.00010522311,0.0001341379,0.99339867,0.00006164229,0.0000112807675,0.0035926942],"study_design_scores_gemma":[0.000018172472,0.0008315543,0.0045350823,0.0000042054376,0.00005611958,0.00020941268,0.000039042985,0.0005019622,0.993306,0.000022765103,0.00046835345,0.0000074640943],"about_ca_topic_score_codex":0.0009298402,"about_ca_topic_score_gemma":0.0007466965,"teacher_disagreement_score":0.0016299116,"about_ca_system_score_codex":0.00027949485,"about_ca_system_score_gemma":0.0002767338,"threshold_uncertainty_score":0.008619964},"labels":[],"label_agreement":null},{"id":"W1980282196","doi":"10.1016/j.biologicals.2014.05.005","title":"The challenge of indication extrapolation for infliximab biosimilars","year":2014,"lang":"en","type":"review","venue":"Biologicals","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":148,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; University of British Columbia; University of Toronto; University of Calgary; University of Alberta; Robarts Clinical Trials; Université de Montréal","funders":"Genentech; Celltrion; UCB; LEO Pharma; Ironwood Pharmaceuticals, Incorporated; Teva Pharmaceutical Industries; Gilead Sciences; ActoGeniX; Sanofi; Celgene; Biogen; GlaxoSmithKline; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Biosimilar; Infliximab; Medicine; Extrapolation; Pharmacology; Internal medicine; Mathematics; Tumor necrosis factor alpha; Statistics","score_opus":0.12163158240022143,"score_gpt":0.40752275257993253,"score_spread":0.2858911701797111,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980282196","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000524615,0.9849182,0.0019279245,0.007247344,0.0008382876,0.000037219666,0.00002608429,0.000025190307,0.0044551296],"genre_scores_gemma":[0.006579083,0.97991896,0.0037765817,0.007011701,0.0010889076,0.00006400452,0.00007128469,0.00001858411,0.0014709039],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99427444,0.002068339,0.0009367411,0.00039024928,0.0021898434,0.00014040622],"domain_scores_gemma":[0.98704904,0.009411496,0.0012338071,0.0003552666,0.0017601427,0.00019022344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011259701,0.0005842834,0.0017353509,0.0023620776,0.0006040737,0.002747276,0.0017894894,0.0038181758,0.0023943845],"category_scores_gemma":[0.012663322,0.00042701553,0.0015083661,0.001878235,0.0022692452,0.0049547777,0.0014652126,0.007064414,0.0015689901],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000069465576,0.000051121056,0.00028539778,0.015285292,0.00007295331,0.0007145735,0.00058071583,0.00050521316,0.0013814808,0.04439732,0.030483188,0.9061732],"study_design_scores_gemma":[0.000022325283,0.000080258156,0.00043154697,0.009910886,0.000079482066,0.0028100372,0.00031795676,0.00017276066,0.00055444264,0.0117494,0.97384506,0.000025793937],"about_ca_topic_score_codex":0.0013786434,"about_ca_topic_score_gemma":0.0017535408,"teacher_disagreement_score":0.011259701,"about_ca_system_score_codex":0.0018732687,"about_ca_system_score_gemma":0.0049408916,"threshold_uncertainty_score":0.059547722},"labels":[],"label_agreement":null},{"id":"W1980971590","doi":"10.1016/j.biologicals.2011.08.001","title":"Risk perception, risk management and safety assessment: What can governments do to increase public confidence in their vaccine system?","year":2011,"lang":"en","type":"article","venue":"Biologicals","topic":"Vaccine Coverage and Hesitancy","field":"Social Sciences","cited_by":93,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Risk perception; Vaccination; Vaccine safety; Public health; Perception; Risk management; Public trust; Medicine; Business; Public relations; Environmental health; Risk analysis (engineering); Immunization; Immunology; Psychology; Political science; Finance; Nursing","score_opus":0.03256947408089026,"score_gpt":0.2852710269424206,"score_spread":0.25270155286153034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980971590","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09756163,0.024725217,0.0032909021,0.85500306,0.00078146404,0.00004872891,0.00009870292,0.000035743054,0.018454563],"genre_scores_gemma":[0.95192504,0.010272846,0.002909242,0.032791775,0.0011203914,0.00008281326,0.00004522714,0.000014424176,0.0008382381],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9751926,0.01752893,0.0005880793,0.00090844504,0.0039474056,0.0018344156],"domain_scores_gemma":[0.8244074,0.12259493,0.02615598,0.0036159859,0.009844075,0.013381674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.038492866,0.0007204222,0.0014555743,0.002263246,0.0021848078,0.011251842,0.0015593123,0.009584077,0.0054803193],"category_scores_gemma":[0.13014811,0.0005311531,0.0010504728,0.0019665146,0.013888659,0.014062498,0.004465782,0.008913064,0.0004479907],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010786512,0.004145628,0.25166643,0.0030835397,0.0013727471,0.000535326,0.026618874,0.0038568259,0.0007213199,0.21511109,0.04799694,0.44381258],"study_design_scores_gemma":[0.0004404864,0.0014069222,0.2599842,0.00775786,0.00064768345,0.0005727686,0.052590195,0.0076792566,0.0008842905,0.61347353,0.054083534,0.00047929623],"about_ca_topic_score_codex":0.016621696,"about_ca_topic_score_gemma":0.015501779,"teacher_disagreement_score":0.038492866,"about_ca_system_score_codex":0.007179988,"about_ca_system_score_gemma":0.016630193,"threshold_uncertainty_score":0.20357221},"labels":[],"label_agreement":null},{"id":"W1983451228","doi":"10.1016/j.biologicals.2013.05.004","title":"Isolation of scFv antibody fragments against HER2 and CEA tumor antigens from combinatorial antibody libraries derived from cancer patients","year":2013,"lang":"en","type":"article","venue":"Biologicals","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph; Carleton University","funders":"","keywords":"Panning (audio); Antibody; Antigen; Molecular biology; Cancer research; Chemistry; Immunology; Biology","score_opus":0.02406813940690559,"score_gpt":0.311601789880519,"score_spread":0.2875336504736134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983451228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95780605,0.0014572664,0.030191878,0.00018622614,0.00008118303,0.00058456464,0.0038376595,0.00039546154,0.0054597436],"genre_scores_gemma":[0.96400917,0.00092493725,0.017310372,0.00037401187,0.00003849802,0.00029299356,0.0102512,0.00011481631,0.00668408],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997603,0.000027128275,0.000015859076,0.00004319734,0.00008268849,0.00007082725],"domain_scores_gemma":[0.99989355,0.000024470371,0.000013199593,0.000011708832,0.00002691243,0.00003007457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018895576,0.00052649766,0.0005218382,0.0006628348,0.00022250376,0.00049909786,0.0003973307,0.00023408269,0.0023765857],"category_scores_gemma":[0.0002907199,0.00025165663,0.00034715582,0.00072952243,0.00011327564,0.00011641405,0.00034618264,0.000705682,0.00083827454],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003365157,0.00009568113,0.0011681842,0.0000642676,0.00004299738,0.00013163648,0.000026569793,0.0006362323,0.9846998,0.00014529453,0.00058396236,0.012068877],"study_design_scores_gemma":[0.00014268412,0.0006887245,0.011185415,0.000023929353,0.00020873634,0.0012899344,0.000065418375,0.0068687615,0.9676808,0.00016572258,0.0116635775,0.000016385362],"about_ca_topic_score_codex":0.0008154518,"about_ca_topic_score_gemma":0.0016059619,"teacher_disagreement_score":0.0023765857,"about_ca_system_score_codex":0.0003327838,"about_ca_system_score_gemma":0.00031489998,"threshold_uncertainty_score":0.007950485},"labels":[],"label_agreement":null},{"id":"W1984123774","doi":"10.1016/j.biologicals.2009.12.004","title":"Application of deglycosylation and electrophoresis to the quantification of influenza viral hemagglutinins facilitating the production of 2009 pandemic influenza (H1N1) vaccines at multiple manufacturing sites in China","year":2010,"lang":"en","type":"article","venue":"Biologicals","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"Health Canada","keywords":"Radial immunodiffusion; Pandemic; Influenza vaccine; Hemagglutinin (influenza); Virology; Vaccination; Microbiology; Medicine; Biology; Coronavirus disease 2019 (COVID-19); Virus; Immunology; Antibody","score_opus":0.06461755601141886,"score_gpt":0.3600427258518038,"score_spread":0.2954251698403849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984123774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851739,0.0013823572,0.012560527,0.00012877793,0.000045489436,0.000053497006,0.000090899295,0.000041303894,0.00052330736],"genre_scores_gemma":[0.977403,0.0012900549,0.020421525,0.000055901128,0.00001831808,0.000034581008,0.00013581623,0.000009467382,0.0006314346],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996294,0.0000669022,0.000033034827,0.0001317201,0.00008694476,0.000052021263],"domain_scores_gemma":[0.9997764,0.000045986522,0.0000502316,0.00002678648,0.00006940342,0.000031275915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085563527,0.00059439015,0.00038263173,0.00049622037,0.0006022462,0.00054160465,0.00036850708,0.00040562442,0.00022666248],"category_scores_gemma":[0.0004530572,0.0003634558,0.00039752183,0.00046636438,0.00060839043,0.00045472253,0.00038187887,0.00045988135,0.000093678784],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000080613434,0.000020735111,0.0021137886,0.0000459918,0.000013444812,0.00003543608,0.00008690783,0.00027470046,0.9908562,0.000059708265,0.000015047312,0.0063974992],"study_design_scores_gemma":[0.000013871656,0.00020706125,0.023579448,0.000007290022,0.000095871656,0.00016606277,0.00010716758,0.003646936,0.9711322,0.000098281926,0.0009256074,0.000020150272],"about_ca_topic_score_codex":0.010295664,"about_ca_topic_score_gemma":0.013245657,"teacher_disagreement_score":0.010295664,"about_ca_system_score_codex":0.0009893968,"about_ca_system_score_gemma":0.00096252654,"threshold_uncertainty_score":0.020471454},"labels":[],"label_agreement":null},{"id":"W1985803217","doi":"10.1016/j.biologicals.2006.05.001","title":"Potency assays for therapeutic live whole cell cancer vaccines","year":2006,"lang":"en","type":"review","venue":"Biologicals","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Clinical trial; Medicine; Cancer vaccine; Disease; Immune system; Infectious disease (medical specialty); Cancer; Vaccine efficacy; Potency; Immunology; Computational biology; Biology; Immunotherapy; Bioinformatics; In vitro","score_opus":0.06482583058028692,"score_gpt":0.343256172539,"score_spread":0.2784303419587131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985803217","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00033772722,0.9892341,0.006679058,0.00038499283,0.0006670929,0.000032816242,0.000056213088,0.000052859916,0.002555177],"genre_scores_gemma":[0.0040185302,0.9828347,0.006629321,0.00059363473,0.0005528331,0.00008633756,0.00019796287,0.000024025749,0.0050626593],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9989938,0.00016367431,0.000087091896,0.00014645027,0.0005343071,0.000074602],"domain_scores_gemma":[0.99874336,0.00070417474,0.00013374146,0.0000655466,0.00029986893,0.000053389376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026348447,0.0030724313,0.0031528748,0.00329947,0.00041345914,0.0017637477,0.0026902873,0.0021435195,0.0028093916],"category_scores_gemma":[0.0022649167,0.00094555377,0.00083249545,0.0030495801,0.0018056631,0.00302576,0.0012012939,0.0042806263,0.0039425595],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012394563,0.00015897444,0.0001565747,0.0062815314,0.000046161815,0.0002147251,0.000061117506,0.0014558828,0.027550433,0.010500477,0.024311185,0.929139],"study_design_scores_gemma":[0.000055547607,0.00034808376,0.00062681886,0.0012018824,0.00008443055,0.0023237288,0.00007168604,0.00096243335,0.030316168,0.0080318395,0.95591104,0.0000663334],"about_ca_topic_score_codex":0.0010234631,"about_ca_topic_score_gemma":0.0014497007,"teacher_disagreement_score":0.00329947,"about_ca_system_score_codex":0.0020983107,"about_ca_system_score_gemma":0.0010412242,"threshold_uncertainty_score":0.015224338},"labels":[],"label_agreement":null},{"id":"W1987479544","doi":"10.1016/j.biologicals.2011.06.003","title":"The first subsequent entry biologic authorized for market in Canada: The story of Omnitrope, a recombinant human growth hormone","year":2011,"lang":"en","type":"review","venue":"Biologicals","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Canada","funders":"","keywords":"Human growth hormone; Guideline; Growth hormone; Product (mathematics); Business; Marketing; Political science; Medicine; Law; Hormone","score_opus":0.10752993073193548,"score_gpt":0.32914068602130137,"score_spread":0.22161075528936588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987479544","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016967679,0.90890825,0.00041777527,0.057444077,0.001645718,0.000047102338,0.00011236882,0.00001343864,0.029714428],"genre_scores_gemma":[0.028649675,0.9243263,0.0013338265,0.022638204,0.00046788834,0.00003526854,0.000100302605,0.000022228784,0.022426324],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958615,0.0007403722,0.00018348302,0.00022349533,0.0026862521,0.0003048629],"domain_scores_gemma":[0.9952958,0.0013838588,0.00034927484,0.00008105011,0.0026034266,0.00028655288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046657184,0.00031989758,0.00055636006,0.0012353408,0.0024161036,0.0040340964,0.00084572716,0.002991267,0.0015895661],"category_scores_gemma":[0.008395195,0.00026165342,0.00031936704,0.0020547123,0.003153113,0.0017022387,0.00079763465,0.0039843414,0.0005907135],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009739847,0.000044686993,0.00076117204,0.0069795703,0.000043938504,0.0021411588,0.0034459108,0.00030413855,0.0024985627,0.11011052,0.4123093,0.46126366],"study_design_scores_gemma":[0.000005382014,0.000015537771,0.0005784879,0.0018185506,0.000019299394,0.0005390464,0.0006492478,0.000024507905,0.00049798953,0.0012491745,0.9945859,0.00001689157],"about_ca_topic_score_codex":0.66444343,"about_ca_topic_score_gemma":0.8587084,"teacher_disagreement_score":0.33555657,"about_ca_system_score_codex":0.023897981,"about_ca_system_score_gemma":0.094243474,"threshold_uncertainty_score":0.6750654},"labels":[],"label_agreement":null},{"id":"W1989847611","doi":"10.1016/j.biologicals.2011.06.015","title":"Quality, safety and efficacy of follow-on biologics in Japan","year":2011,"lang":"en","type":"review","venue":"Biologicals","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biosimilar; Comparability; Harmonization; Medicine; Quality (philosophy); Product (mathematics); Scientific evidence; Drug approval; Pharmacovigilance; Risk analysis (engineering); Business; Pharmacology; Adverse effect; Internal medicine; Drug","score_opus":0.22196667777815177,"score_gpt":0.4229495287818701,"score_spread":0.20098285100371832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989847611","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005204319,0.99832886,0.00009350441,0.00027653945,0.00005541892,0.0000048698917,0.000008190749,0.0000019053826,0.0007102097],"genre_scores_gemma":[0.0064286133,0.99238855,0.00039212176,0.00021674657,0.000114106915,0.0000134921875,0.000025533765,0.0000017035297,0.00041903657],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983187,0.0003281534,0.0004251049,0.0002160662,0.00064256846,0.00006952524],"domain_scores_gemma":[0.9981615,0.0006681317,0.00050862617,0.000043595046,0.0005585351,0.000059604863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033447915,0.00048488213,0.0012846794,0.0017036452,0.00033793028,0.0011888025,0.0006631087,0.0012167594,0.001020866],"category_scores_gemma":[0.0027416574,0.00026460364,0.00053181726,0.0018515333,0.0007518507,0.0011168023,0.00055137445,0.0009510272,0.00034955237],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000115260664,0.000059479305,0.001040205,0.018039923,0.000079373196,0.00026465935,0.00019297503,0.00019952402,0.0025088363,0.003381752,0.005866485,0.9682514],"study_design_scores_gemma":[0.000054587887,0.000560512,0.013348366,0.009427338,0.0005333712,0.0036816795,0.00045577975,0.00026292625,0.009213671,0.0029365313,0.95945925,0.000065900465],"about_ca_topic_score_codex":0.0043136184,"about_ca_topic_score_gemma":0.0043602143,"teacher_disagreement_score":0.0043136184,"about_ca_system_score_codex":0.0015100604,"about_ca_system_score_gemma":0.0029384801,"threshold_uncertainty_score":0.017689168},"labels":[],"label_agreement":null},{"id":"W2002321378","doi":"10.1016/j.biologicals.2009.01.004","title":"Role of regulatory agencies","year":2009,"lang":"en","type":"review","venue":"Biologicals","topic":"Blood donation and transfusion practices","field":"Business, Management and Accounting","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Regulatory authority; Perspective (graphical); Business; Risk analysis (engineering); Quality (philosophy); Political science; Computer science; Public administration","score_opus":0.077021149111106,"score_gpt":0.3085727936760933,"score_spread":0.2315516445649873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002321378","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00062468543,0.92237705,0.0016618745,0.01817431,0.0034905132,0.00008930124,0.00013647598,0.00006258106,0.05338331],"genre_scores_gemma":[0.021628112,0.92412204,0.003909843,0.021788405,0.0026768993,0.0002394593,0.0002562265,0.000032287906,0.025346689],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9923459,0.0027188305,0.0009286993,0.0010614912,0.0022911262,0.0006538012],"domain_scores_gemma":[0.9875135,0.005724652,0.002265675,0.0007070532,0.0032924693,0.00049671583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0125106005,0.0012614917,0.0015587696,0.0037791834,0.0011002383,0.00577542,0.0024536464,0.0057534343,0.012441102],"category_scores_gemma":[0.015473044,0.0005418525,0.00088743115,0.0042230487,0.003226121,0.004520606,0.0023913395,0.004603197,0.004344539],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009093457,0.0001092929,0.00068494445,0.008891656,0.00008867935,0.00036541602,0.00037885032,0.00023295039,0.0008627023,0.097266026,0.11838495,0.7726436],"study_design_scores_gemma":[0.000018614137,0.00002170826,0.00035245327,0.004038678,0.00004636522,0.0001925118,0.00010587285,0.000037032263,0.00017493562,0.0028064179,0.99219817,0.0000072814387],"about_ca_topic_score_codex":0.0041611847,"about_ca_topic_score_gemma":0.00484526,"teacher_disagreement_score":0.0125106005,"about_ca_system_score_codex":0.00272739,"about_ca_system_score_gemma":0.014257258,"threshold_uncertainty_score":0.06616318},"labels":[],"label_agreement":null},{"id":"W2007964716","doi":"10.1016/j.biologicals.2011.08.009","title":"WHO/KFDA joint workshop on implementing WHO guidelines on evaluating similar biotherapeutic products, Seoul, Republic of Korea 24–26 August, 2010","year":2011,"lang":"en","type":"review","venue":"Biologicals","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"U.S. Food and Drug Administration; Pan American Health Organization; Korea Food and Drug Administration","keywords":"Comparability; Terminology; Reimbursement; Quality (philosophy); Directive; Business; Diversity (politics); Food and drug administration; Medicine; Biotechnology; Process management; Political science; Risk analysis (engineering); Computer science; Health care; Biology","score_opus":0.4036703566443834,"score_gpt":0.44595389250951556,"score_spread":0.04228353586513217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007964716","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003520804,0.86341155,0.011966908,0.06481733,0.018269349,0.0029106543,0.0013823485,0.00025200774,0.033469],"genre_scores_gemma":[0.024553107,0.8563415,0.039443437,0.028535914,0.003334824,0.0029312354,0.0036269873,0.00012901373,0.04110396],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99435955,0.002463888,0.0011480212,0.00031269295,0.0012682435,0.00044758376],"domain_scores_gemma":[0.9933941,0.0017154856,0.0010367584,0.00024730066,0.0030957647,0.0005105268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019468162,0.0015386443,0.0015284133,0.0034504284,0.0006166803,0.00205241,0.0025736513,0.003956873,0.004751638],"category_scores_gemma":[0.009115416,0.0007367493,0.0020780615,0.0023093743,0.0009924939,0.002832605,0.0024176752,0.0033718082,0.0026126078],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031698117,0.00041415577,0.00079496787,0.020208575,0.00019506372,0.0013526651,0.0011101366,0.00073407224,0.0055994326,0.009281198,0.38914484,0.57084787],"study_design_scores_gemma":[0.000055699216,0.0001440868,0.0015716051,0.008147873,0.00011304748,0.00074240554,0.00035684978,0.00006540802,0.0016413901,0.0011876534,0.9859389,0.000035055564],"about_ca_topic_score_codex":0.0052006547,"about_ca_topic_score_gemma":0.007625879,"teacher_disagreement_score":0.019468162,"about_ca_system_score_codex":0.003642524,"about_ca_system_score_gemma":0.01724942,"threshold_uncertainty_score":0.10295868},"labels":[],"label_agreement":null},{"id":"W2019553456","doi":"10.1016/j.biologicals.2004.07.001","title":"Assessment of the viral safety of antivenoms fractionated from equine plasma","year":2004,"lang":"en","type":"review","venue":"Biologicals","topic":"Venomous Animal Envenomation and Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":74,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Virology; Chemistry; Medicine; Chromatography","score_opus":0.04088139963661249,"score_gpt":0.3486313691422732,"score_spread":0.30774996950566075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019553456","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010472722,0.9967393,0.0004722788,0.00013439952,0.000097388736,0.000008863588,0.000030569594,0.000006975419,0.0014628344],"genre_scores_gemma":[0.0043604095,0.9927584,0.0006688454,0.00016718234,0.00008146712,0.000014157309,0.0000807866,0.0000020563973,0.001866608],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99982685,0.000019951653,0.000019978937,0.000035348443,0.00008218477,0.000015640067],"domain_scores_gemma":[0.9996563,0.0001502089,0.000046195488,0.000011584978,0.00011871074,0.000016988019],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086625875,0.0010129348,0.0014323136,0.0013670783,0.00024446507,0.0010015358,0.000972523,0.0010763992,0.0014839479],"category_scores_gemma":[0.0006531825,0.00022142315,0.0003226167,0.0012584578,0.000444092,0.00091357547,0.00029392744,0.000942106,0.0010543363],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022257728,0.000104282364,0.00027633962,0.0070831785,0.00007263654,0.00026455082,0.000045186684,0.0004343655,0.016735578,0.0018612794,0.005957173,0.9669429],"study_design_scores_gemma":[0.00008669195,0.0008773431,0.0029081737,0.0026570337,0.00031273355,0.0031936262,0.00015118437,0.00036808345,0.035216466,0.0023568757,0.9518182,0.00005365247],"about_ca_topic_score_codex":0.0015775566,"about_ca_topic_score_gemma":0.0016960583,"teacher_disagreement_score":0.0015775566,"about_ca_system_score_codex":0.0007531558,"about_ca_system_score_gemma":0.0008829218,"threshold_uncertainty_score":0.005464494},"labels":[],"label_agreement":null},{"id":"W2019940052","doi":"10.1016/j.biologicals.2006.02.008","title":"Developments in the production and quality control of poliovirus vaccines – Historical perspectives","year":2006,"lang":"en","type":"article","venue":"Biologicals","topic":"Viral Infections and Immunology Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Poliovirus; Virology; Poliomyelitis; Attenuated vaccine; Medicine; Inactivated Poliovirus Vaccine; Virus; Poliomyelitis vaccine; Biology; Immunization; Immunology; Antibody","score_opus":0.07321940373663421,"score_gpt":0.3617862490188297,"score_spread":0.2885668452821955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019940052","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0062739165,0.93211675,0.0064472305,0.020582477,0.0022791114,0.000021471295,0.000040140712,0.000023903192,0.03221502],"genre_scores_gemma":[0.106230035,0.87106764,0.0059633963,0.0043911966,0.007234831,0.00003817687,0.00006028888,0.000021656875,0.0049927714],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99840814,0.0006126808,0.0001333941,0.00022262085,0.0004631744,0.00015994976],"domain_scores_gemma":[0.99548906,0.0024068211,0.0005863118,0.00021420566,0.0010240498,0.0002794949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008054617,0.0007721874,0.00056147046,0.0023834931,0.0009581375,0.0045591206,0.0010545298,0.0023214335,0.003289271],"category_scores_gemma":[0.004481031,0.0003179762,0.0003347174,0.002369387,0.0052107843,0.005213116,0.0015321966,0.0029817375,0.000775755],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045184363,0.00039667287,0.002100646,0.0042721843,0.0000688036,0.00058863807,0.0010698427,0.002656243,0.007771794,0.49891227,0.014153223,0.4675578],"study_design_scores_gemma":[0.000044439115,0.00072258734,0.0023693722,0.0017989324,0.000042430638,0.0007833412,0.00083734235,0.0008366084,0.007543243,0.08053138,0.9044183,0.000072202834],"about_ca_topic_score_codex":0.001630198,"about_ca_topic_score_gemma":0.0012459845,"teacher_disagreement_score":0.008054617,"about_ca_system_score_codex":0.003911448,"about_ca_system_score_gemma":0.0023617316,"threshold_uncertainty_score":0.042597353},"labels":[],"label_agreement":null},{"id":"W2021405109","doi":"10.1016/j.biologicals.2013.11.011","title":"Report on the international workshop on alternatives to the murine histamine sensitization test (HIST) for acellular pertussis vaccines: State of the science and the path forward","year":2014,"lang":"en","type":"article","venue":"Biologicals","topic":"Bacterial Infections and Vaccines","field":"Immunology and Microbiology","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada); Health Canada","funders":"National Institutes of Health; U.S. Food and Drug Administration; Henan Institute of Science and Technology; National Institute of Environmental Health Sciences; University of Virginia","keywords":"Test (biology); Medicine; Immunology; Biology","score_opus":0.018992041529765327,"score_gpt":0.256287146343748,"score_spread":0.23729510481398267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021405109","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09434851,0.13580306,0.08542693,0.4179819,0.14751112,0.007078414,0.0073203123,0.00065884506,0.10387094],"genre_scores_gemma":[0.2506776,0.06991632,0.0679737,0.22270672,0.04769176,0.0050639347,0.015182635,0.00078488956,0.32000247],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9933981,0.0017902431,0.00050959724,0.00087622926,0.0023021665,0.0011237136],"domain_scores_gemma":[0.9894019,0.0033741088,0.00085713365,0.00037199288,0.004318948,0.001676035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.021139659,0.0020015447,0.00085933984,0.0010198948,0.0014380243,0.0038532878,0.0040658857,0.012811929,0.009855057],"category_scores_gemma":[0.010000522,0.00057506724,0.0019108406,0.0006768571,0.0015886954,0.0026245147,0.002706484,0.010040902,0.00364567],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005430091,0.0043939403,0.013840158,0.00305418,0.000385106,0.0032171458,0.0015829812,0.0031451888,0.06815023,0.014435948,0.44538003,0.43698505],"study_design_scores_gemma":[0.00023082076,0.0023917933,0.008261753,0.00060211995,0.00025109464,0.00058802095,0.0010109879,0.0007488299,0.0415628,0.0034880745,0.9407238,0.00013996277],"about_ca_topic_score_codex":0.006567245,"about_ca_topic_score_gemma":0.0069334526,"teacher_disagreement_score":0.021139659,"about_ca_system_score_codex":0.0021134214,"about_ca_system_score_gemma":0.00680876,"threshold_uncertainty_score":0.111798584},"labels":[],"label_agreement":null},{"id":"W2023560212","doi":"10.1016/j.biologicals.2006.03.008","title":"Polio vaccine development in Canada: Contributions to global polio eradication","year":2006,"lang":"en","type":"article","venue":"Biologicals","topic":"Viral Infections and Immunology Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Heritage; Sanofi (Canada)","funders":"Hospital for Sick Children; World Bank Group","keywords":"Poliomyelitis; Poliomyelitis eradication; Disease Eradication; Political science; Polio vaccine; Polio Vaccination; Economic growth; Immunization; Medicine; Virology; Poliovirus; Economics; Immunology","score_opus":0.01734293174339808,"score_gpt":0.32757614124104717,"score_spread":0.3102332094976491,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023560212","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19113387,0.12476344,0.0024291573,0.4927256,0.0054712757,0.00036769328,0.0035022642,0.0002443968,0.17936231],"genre_scores_gemma":[0.7925903,0.09254785,0.0049233465,0.028681578,0.0011088158,0.000074643365,0.0011333436,0.00009821843,0.0788419],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980001,0.00024263115,0.000054314467,0.0001128966,0.00067518745,0.0009148887],"domain_scores_gemma":[0.994839,0.000341667,0.0002458669,0.00005294434,0.0025957243,0.0019249053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022329458,0.0005964817,0.00036989382,0.00131802,0.0032542278,0.0039299196,0.0008078299,0.0013697539,0.010865332],"category_scores_gemma":[0.004978042,0.00020093174,0.00050450425,0.0018195153,0.0013228065,0.0008634996,0.0015389844,0.0025442047,0.0004941421],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013576383,0.00051507505,0.11593296,0.001914071,0.00032407988,0.0011912311,0.0022323087,0.0044529615,0.0052977065,0.06087387,0.16967191,0.6362362],"study_design_scores_gemma":[0.0003554647,0.0004322026,0.20531408,0.0013028692,0.0005125342,0.00051855086,0.006523401,0.0032250488,0.0055950056,0.0058973655,0.7702153,0.00010822214],"about_ca_topic_score_codex":0.98778117,"about_ca_topic_score_gemma":0.9942983,"teacher_disagreement_score":0.0822268,"about_ca_system_score_codex":0.0822268,"about_ca_system_score_gemma":0.28620324,"threshold_uncertainty_score":0.59659994},"labels":[],"label_agreement":null},{"id":"W2024080232","doi":"10.1016/j.biologicals.2013.03.003","title":"Serogroup quantitation of multivalent polysaccharide and polysaccharide-conjugate meningococcal vaccines from China","year":2013,"lang":"en","type":"article","venue":"Biologicals","topic":"Bacterial Infections and Vaccines","field":"Immunology and Microbiology","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"Health Canada","keywords":"Polysaccharide; Conjugate; Microbiology; Neisseria meningitidis; Meningococcal vaccine; Conjugate vaccine; Meningococcal meningitis; Virology; Chemistry; Biology; Bacteria; Antibiotics; Biochemistry; Streptococcus pneumoniae","score_opus":0.016801315187519855,"score_gpt":0.24621596020069636,"score_spread":0.22941464501317652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024080232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99689484,0.0007657359,0.0006318391,0.0000335933,0.000021509783,0.000016280113,0.00024100626,0.000011512873,0.0013836479],"genre_scores_gemma":[0.99575305,0.00047008478,0.0006742033,0.000043445543,0.000013541546,0.000015213008,0.0007984356,0.000005254347,0.002226758],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998159,0.000024011943,0.000017939885,0.00003245112,0.0000707387,0.00003888475],"domain_scores_gemma":[0.9998293,0.000015755362,0.000026297044,0.000014373358,0.000073266565,0.000040877687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045363588,0.0006246548,0.0002445082,0.0010175344,0.0003507802,0.0003143984,0.00017637896,0.00021136718,0.00047511802],"category_scores_gemma":[0.0004463954,0.00013177985,0.00019760305,0.0006952729,0.00024344887,0.00019272025,0.00032776204,0.00023297343,0.00012770985],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005770698,0.00008457502,0.07417632,0.00015750535,0.000077785575,0.00011102333,0.00043055828,0.000887767,0.8915449,0.00036876297,0.00041720437,0.03116654],"study_design_scores_gemma":[0.000052257987,0.0011572136,0.46304,0.000043884935,0.00026350995,0.00033337204,0.0005198512,0.0038275444,0.51604515,0.00033395024,0.01434829,0.000034938806],"about_ca_topic_score_codex":0.015820188,"about_ca_topic_score_gemma":0.012064862,"teacher_disagreement_score":0.015820188,"about_ca_system_score_codex":0.0006422548,"about_ca_system_score_gemma":0.0010001904,"threshold_uncertainty_score":0.031456172},"labels":[],"label_agreement":null},{"id":"W2024454736","doi":"10.1016/j.biologicals.2009.08.018","title":"WHO/KFDA workshop on stability evaluation of vaccines, Seoul, Korea, 23–25 April 2008","year":2009,"lang":"en","type":"article","venue":"Biologicals","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Stability (learning theory); Food and drug administration; Computer science; Operations research; Estimation; Risk analysis (engineering); Medicine; Engineering; Machine learning; Systems engineering","score_opus":0.1377073172535528,"score_gpt":0.36916911471399655,"score_spread":0.23146179746044374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024454736","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.059927177,0.58021826,0.0638669,0.1023695,0.032984678,0.0040413653,0.010336703,0.001494075,0.14476138],"genre_scores_gemma":[0.2586879,0.26118043,0.100779176,0.01846894,0.0107477475,0.002992606,0.017367885,0.0011705636,0.32860473],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99647564,0.0013128024,0.00039786898,0.00023511215,0.0010862303,0.00049235515],"domain_scores_gemma":[0.99586475,0.0007506366,0.00047153485,0.0003193889,0.0021484003,0.00044526797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01814514,0.0018891844,0.0009880258,0.0023594091,0.0010197491,0.002205473,0.0029245757,0.0030390935,0.008671763],"category_scores_gemma":[0.005828552,0.00086795905,0.001226201,0.0010853915,0.0013813023,0.0020631745,0.0024574378,0.0019349958,0.00339461],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015015367,0.0007193628,0.0049784966,0.0021131265,0.00014263528,0.0006980384,0.0010259496,0.0018996885,0.023601877,0.004695337,0.41622275,0.5424012],"study_design_scores_gemma":[0.00009834973,0.000603455,0.009220886,0.0014203818,0.0001456623,0.0007438345,0.00062562665,0.00039577755,0.021462021,0.0020053885,0.9632395,0.000039203842],"about_ca_topic_score_codex":0.008961077,"about_ca_topic_score_gemma":0.012247278,"teacher_disagreement_score":0.01814514,"about_ca_system_score_codex":0.0024340579,"about_ca_system_score_gemma":0.006599112,"threshold_uncertainty_score":0.09596187},"labels":[],"label_agreement":null},{"id":"W2025748901","doi":"10.1016/j.biologicals.2009.08.016","title":"Characterization of variant diphtheria toxin–interleukin-3 fusion protein, DTIL3K116W, for phase I clinical trials","year":2009,"lang":"en","type":"article","venue":"Biologicals","topic":"Toxin Mechanisms and Immunotoxins","field":"Immunology and Microbiology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Diphtheria toxin; Diphtheria; Toxin; Microbiology; Medicine; Virology; Chemistry; Biology; Vaccination","score_opus":0.11153700088426086,"score_gpt":0.3937684916551069,"score_spread":0.2822314907708461,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025748901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98887116,0.002127577,0.0041616093,0.00058290805,0.00009698998,0.00082683447,0.0017198297,0.000060094513,0.0015530057],"genre_scores_gemma":[0.98769844,0.0009275059,0.0038776044,0.00027979485,0.000023474526,0.00035122092,0.004961912,0.000027269414,0.001852845],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997999,0.000034209457,0.000014953971,0.000025418914,0.000044141998,0.00008142978],"domain_scores_gemma":[0.9998466,0.000026332737,0.000028386014,0.000018004142,0.00003177528,0.000048884034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005295658,0.00050645147,0.00045417456,0.00023237069,0.00026454186,0.0005565659,0.00041646019,0.00053056114,0.0020314385],"category_scores_gemma":[0.00041379567,0.00018639826,0.00043589916,0.00030920707,0.00029261556,0.00021458164,0.00017971912,0.0009966285,0.00071787956],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004419574,0.0009984603,0.0017908972,0.00011660049,0.000058835412,0.0002243165,0.000068740585,0.0015294278,0.9707281,0.00037191223,0.001581194,0.018111976],"study_design_scores_gemma":[0.008207598,0.039931558,0.016072059,0.000058594444,0.00048468285,0.0021873896,0.00013014454,0.006516003,0.8971968,0.0004664235,0.028711347,0.000037458154],"about_ca_topic_score_codex":0.001322991,"about_ca_topic_score_gemma":0.0015594444,"teacher_disagreement_score":0.0020314385,"about_ca_system_score_codex":0.0007603071,"about_ca_system_score_gemma":0.0009247472,"threshold_uncertainty_score":0.006795883},"labels":[],"label_agreement":null},{"id":"W2033051200","doi":"10.1016/j.biologicals.2012.09.010","title":"Health Canada/BIOTECanada Summit on regulatory and clinical topics related to subsequent entry biologics (biosimilars), Ottawa, Canada, 14 May 2012","year":2012,"lang":"en","type":"article","venue":"Biologicals","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Health Canada; University of Toronto; University Health Network; Health Sciences Centre; Mount Sinai Hospital; Western University","funders":"Health Canada","keywords":"Biosimilar; Summit; Medicine; Pharmacovigilance; Comparability; Product (mathematics); Interchangeability; Health care; Family medicine; Pharmacology; Political science; Drug","score_opus":0.040734856054130394,"score_gpt":0.31990770629134835,"score_spread":0.27917285023721794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033051200","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013291054,0.047358446,0.0019189382,0.63826203,0.034709014,0.0020999706,0.017829249,0.0004933468,0.24403791],"genre_scores_gemma":[0.06781849,0.017207881,0.0053967885,0.21361805,0.0044862204,0.0005130394,0.011600553,0.00024578473,0.67911327],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9809194,0.0010506304,0.00048028983,0.0009759291,0.011194055,0.0053797327],"domain_scores_gemma":[0.9793545,0.0019337523,0.0006694932,0.00045228604,0.010325903,0.007264002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018495614,0.001370448,0.0009123181,0.0023161597,0.014035964,0.009073462,0.003398303,0.015194697,0.025856635],"category_scores_gemma":[0.013584546,0.0008599894,0.0014718454,0.0016747207,0.0043704873,0.0014696788,0.0033862814,0.008298879,0.0048188707],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010480027,0.000072307805,0.00078404206,0.00009127488,0.000008505373,0.00016154908,0.0001529542,0.00010855878,0.00039891154,0.0018941828,0.9885079,0.007714955],"study_design_scores_gemma":[0.000051226263,0.000041667194,0.0057956027,0.00015069752,0.000017608103,0.000046802896,0.0005017561,0.00011198729,0.0006196094,0.00043277018,0.99219525,0.000035028086],"about_ca_topic_score_codex":0.94174325,"about_ca_topic_score_gemma":0.983914,"teacher_disagreement_score":0.9065729,"about_ca_system_score_codex":0.09342714,"about_ca_system_score_gemma":0.26857102,"threshold_uncertainty_score":0.6778645},"labels":[],"label_agreement":null},{"id":"W2034043843","doi":"10.1006/biol.2002.0322","title":"Thermal Stability: A Means to Assure Tertiary Structure in Therapeutic Proteins","year":2002,"lang":"en","type":"article","venue":"Biologicals","topic":"Enzyme Structure and Function","field":"Materials Science","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Protein tertiary structure; Protein secondary structure; Denaturation (fissile materials); Chemistry; Protein structure; Protein folding; Chemical structure; Amino acid; Protein primary structure; Biochemistry; Crystallography; Biophysics; Peptide sequence; Organic chemistry; Biology","score_opus":0.03560368562267057,"score_gpt":0.2410658868471672,"score_spread":0.20546220122449663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034043843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.627938,0.012556269,0.34306103,0.0021755523,0.00046651144,0.00018117069,0.00031390367,0.0017052306,0.011602436],"genre_scores_gemma":[0.9460846,0.0019941097,0.046404522,0.00048424257,0.00019068738,0.000116317555,0.00022229817,0.0003234811,0.004179688],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993631,0.00019603183,0.000053375756,0.00009890953,0.00022064048,0.00006799372],"domain_scores_gemma":[0.9987483,0.00030372798,0.00033146446,0.00022562474,0.00028162726,0.000109236906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019231938,0.0005664793,0.00048516807,0.0005600757,0.00069775805,0.0012585417,0.00057904766,0.0007807684,0.001709102],"category_scores_gemma":[0.0024768303,0.00037339854,0.00039099634,0.00026665782,0.0009570773,0.0014895989,0.00057452713,0.0014514937,0.0008072678],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003005651,0.00004656226,0.00053215044,0.00012044562,0.000016756358,0.000062781684,0.000118939686,0.0013204676,0.9694957,0.0063816775,0.00054612505,0.021057839],"study_design_scores_gemma":[0.000016461341,0.00034702587,0.00075606967,0.000016215328,0.000028730534,0.00043026832,0.00002627902,0.0038058257,0.9866583,0.002524136,0.0053685075,0.000022208435],"about_ca_topic_score_codex":0.00014702044,"about_ca_topic_score_gemma":0.00017609094,"teacher_disagreement_score":0.0019231938,"about_ca_system_score_codex":0.00049985916,"about_ca_system_score_gemma":0.00038599534,"threshold_uncertainty_score":0.010170937},"labels":[],"label_agreement":null},{"id":"W2036701515","doi":"10.1016/j.biologicals.2009.12.005","title":"Approach to the profiling and characterization of influenza vaccine constituents by the combined use of size-exclusion chromatography, gel electrophoresis and mass spectrometry","year":2010,"lang":"en","type":"article","venue":"Biologicals","topic":"Protein purification and stability","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"Health Canada","keywords":"Chromatography; Size-exclusion chromatography; Mass spectrometry; Influenza vaccine; Chemistry; Biology; Virology","score_opus":0.013319332817672357,"score_gpt":0.24085189056345518,"score_spread":0.22753255774578282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036701515","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2486538,0.0131443525,0.7281997,0.002166289,0.00034818106,0.0009436328,0.0018121741,0.001143482,0.0035883836],"genre_scores_gemma":[0.36715126,0.011598967,0.61122054,0.0016343346,0.00017465535,0.0010868462,0.0023453142,0.00017402686,0.004614068],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992617,0.00014941127,0.000058081656,0.00015524775,0.00032253357,0.000052939453],"domain_scores_gemma":[0.9993611,0.00017272118,0.000107593325,0.00008270365,0.00020923394,0.000066726876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011068913,0.0012966378,0.0010747587,0.0017496195,0.0007595692,0.0014353557,0.0009004553,0.00094882504,0.00070099],"category_scores_gemma":[0.0010815545,0.0005417381,0.00079096184,0.0006533331,0.00084257574,0.0008095098,0.000999673,0.0027703492,0.00076044735],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005391342,0.00009481376,0.00031803685,0.00008791649,0.00004105524,0.000027247728,0.000029190367,0.000086476575,0.9917162,0.00027223534,0.00013544579,0.0071374215],"study_design_scores_gemma":[0.000024387336,0.00047293562,0.0048000594,0.000020151325,0.00010618612,0.0013124384,0.000080216116,0.004768329,0.9798768,0.0009452053,0.007537972,0.000055278513],"about_ca_topic_score_codex":0.0010431082,"about_ca_topic_score_gemma":0.0020710565,"teacher_disagreement_score":0.0017496195,"about_ca_system_score_codex":0.00047502472,"about_ca_system_score_gemma":0.00095743116,"threshold_uncertainty_score":0.005853832},"labels":[],"label_agreement":null},{"id":"W2059265705","doi":"10.1016/j.biologicals.2012.09.008","title":"WHO/Health Canada meeting on regulatory considerations for evaluation and licensing of new meningococcal Group B vaccines, Ottawa, Canada, 3–4 October 2011","year":2012,"lang":"en","type":"article","venue":"Biologicals","topic":"Bacterial Infections and Vaccines","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Canada","funders":"","keywords":"Immunogenicity; Neisseria meningitidis; Meningococcal vaccine; Standardization; Virology; Outbreak; Medicine; Biology; Antigen; Political science; Immunology; Bacteria; Genetics","score_opus":0.04348790936497547,"score_gpt":0.2869290772448645,"score_spread":0.243441167879889,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059265705","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0132978875,0.064918265,0.0048174975,0.6978876,0.061789177,0.00417628,0.015903857,0.00045599576,0.13675354],"genre_scores_gemma":[0.061036337,0.035064045,0.018899959,0.35448736,0.011778388,0.0011484472,0.00889869,0.0004370473,0.50824976],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9858451,0.0015312089,0.0008808201,0.00070049486,0.007165987,0.003876433],"domain_scores_gemma":[0.9824181,0.0019447136,0.0010211921,0.00027048087,0.00970586,0.0046395827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017759092,0.0019280894,0.0011725392,0.0023252147,0.008186075,0.005919512,0.005627343,0.029337231,0.011285526],"category_scores_gemma":[0.014100993,0.0017609441,0.0026753398,0.0021240138,0.003561167,0.0017164832,0.002073267,0.016080935,0.0024612516],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029339723,0.00012781029,0.0016106743,0.00028558736,0.00004439273,0.00044260526,0.00030910852,0.0004399003,0.0013907198,0.0017209501,0.98231643,0.011018283],"study_design_scores_gemma":[0.00012072172,0.00007007023,0.015932526,0.0006410098,0.0000932674,0.00016548597,0.0006663083,0.00027870457,0.0009567305,0.0004837269,0.9804749,0.00011660504],"about_ca_topic_score_codex":0.9387767,"about_ca_topic_score_gemma":0.980473,"teacher_disagreement_score":0.061223328,"about_ca_system_score_codex":0.050609924,"about_ca_system_score_gemma":0.2358129,"threshold_uncertainty_score":0.3672024},"labels":[],"label_agreement":null},{"id":"W2059662302","doi":"10.1016/j.biologicals.2014.05.001","title":"Results of an international transferability study of the BINACLE (binding and cleavage) assay for in vitro detection of tetanus toxicity","year":2014,"lang":"en","type":"article","venue":"Biologicals","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Transferability; Toxicity; In vitro; Tetanus; Cleavage (geology); Chemistry; Pharmacology; Biochemistry; Medicine; Biology; Immunology; Computer science; Organic chemistry","score_opus":0.03225434546825608,"score_gpt":0.2928911571924868,"score_spread":0.26063681172423075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059662302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9293416,0.0015726206,0.0567504,0.00018311558,0.0000948454,0.0005252675,0.0011793311,0.00018400837,0.0101688355],"genre_scores_gemma":[0.9752083,0.0005975489,0.014753218,0.0000993052,0.000019564966,0.00016703337,0.0035039324,0.00009713829,0.0055540227],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969637,0.0011383655,0.00025382283,0.0005792131,0.00071876514,0.00034605234],"domain_scores_gemma":[0.99794096,0.0007223697,0.00014592025,0.00048582742,0.0005365621,0.00016832295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032357231,0.0011635958,0.0007139028,0.0008029818,0.0006250693,0.0006808041,0.0008460815,0.000796777,0.0023779268],"category_scores_gemma":[0.0024581065,0.00034114765,0.0010725372,0.0007694062,0.0007892039,0.00050937396,0.00076814106,0.0011519898,0.0010885234],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064565614,0.00031441508,0.0011870282,0.000040801002,0.000044854274,0.00004437561,0.00016174611,0.00028758892,0.9917365,0.00021481709,0.000085243715,0.0052370094],"study_design_scores_gemma":[0.000021543912,0.0013256388,0.0066167186,0.0000043041255,0.000078976875,0.00015347842,0.00005577375,0.00057141355,0.9895375,0.00009642226,0.0015241451,0.000014013344],"about_ca_topic_score_codex":0.0034896536,"about_ca_topic_score_gemma":0.0016222881,"teacher_disagreement_score":0.0034896536,"about_ca_system_score_codex":0.0006381794,"about_ca_system_score_gemma":0.0004230828,"threshold_uncertainty_score":0.017112374},"labels":[],"label_agreement":null},{"id":"W2061592265","doi":"10.1016/j.biologicals.2011.09.004","title":"Evaluation of similar biotherapeutic products: Scientific and regulatory challenges","year":2011,"lang":"en","type":"editorial","venue":"Biologicals","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Biochemical engineering; Computational biology; Chemistry; Computer science; Biology; Engineering","score_opus":0.10610936778380496,"score_gpt":0.32570991743955285,"score_spread":0.21960054965574788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061592265","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000098042015,0.020110244,0.00043860928,0.0656877,0.9109339,0.000038556136,0.00005496272,0.000051278494,0.002586756],"genre_scores_gemma":[0.0011249566,0.014583247,0.0007390004,0.060955927,0.9088522,0.000052720145,0.000047036367,0.000042962914,0.013601912],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98270214,0.0035677783,0.0025262316,0.0012196628,0.009261357,0.0007227766],"domain_scores_gemma":[0.94314563,0.032065414,0.0031088353,0.0011473424,0.017273737,0.0032590101],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020333208,0.0038898732,0.0050689895,0.0033466856,0.003622706,0.010200063,0.00594698,0.04589105,0.0048315786],"category_scores_gemma":[0.038295165,0.0016198393,0.004422714,0.0016983738,0.004512699,0.0056584757,0.0021714289,0.035565313,0.0052559413],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000101451624,0.000042701668,0.000035314035,0.00052633014,0.00007064845,0.00035649055,0.0000271368,0.0000834738,0.00025483564,0.0010066539,0.98348874,0.014006307],"study_design_scores_gemma":[0.00007941025,0.000079066194,0.00028702192,0.0006593272,0.00016176056,0.000593264,0.000053732023,0.00025901428,0.00041743607,0.0020355934,0.9953376,0.000036674497],"about_ca_topic_score_codex":0.0022983972,"about_ca_topic_score_gemma":0.006314347,"teacher_disagreement_score":0.04589105,"about_ca_system_score_codex":0.0045334967,"about_ca_system_score_gemma":0.0050391895,"threshold_uncertainty_score":0.10753363},"labels":[],"label_agreement":null},{"id":"W2070941941","doi":"10.1016/j.biologicals.2011.11.001","title":"Preparation of blood products for transfusion: Is there a best method?","year":2011,"lang":"en","type":"review","venue":"Biologicals","topic":"Blood donation and transfusion practices","field":"Business, Management and Accounting","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of British Columbia","funders":"","keywords":"Buffy coat; Blood component; Apheresis; Production (economics); Blood donor; Whole blood; Intensive care medicine; Blood collection; Plateletpheresis; Medicine; Platelet; Surgery; Immunology; Medical emergency","score_opus":0.16823236442323372,"score_gpt":0.3922269800614754,"score_spread":0.22399461563824166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070941941","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000040708892,0.99933463,0.000050248495,0.0003285506,0.000069111054,0.0000017183613,0.000005499931,0.0000018740076,0.00016759228],"genre_scores_gemma":[0.00035102878,0.999126,0.00018205804,0.00016637455,0.00008371822,0.0000028600998,0.0000073520964,6.176493e-7,0.00007996056],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991411,0.00017805804,0.00019436204,0.00012805838,0.00031181896,0.000046512425],"domain_scores_gemma":[0.9963903,0.0021749965,0.00067816523,0.00006650853,0.00058335846,0.00010678864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002589517,0.0010846582,0.0039947876,0.0030336601,0.0005229683,0.0021774264,0.0015616422,0.0021443744,0.002930763],"category_scores_gemma":[0.0040818523,0.00055343634,0.00097157893,0.0046085333,0.0014339855,0.002475233,0.0006662952,0.0026009232,0.0012655214],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007402092,0.000085222026,0.0003602962,0.035222184,0.00018613064,0.00011710878,0.000069395915,0.00016262372,0.00063113455,0.002010305,0.015980259,0.9451013],"study_design_scores_gemma":[0.00006473116,0.0002202326,0.0032300982,0.045103632,0.0011631637,0.0017176474,0.00048288866,0.00015477944,0.00096497085,0.003998484,0.94282156,0.00007778978],"about_ca_topic_score_codex":0.003886326,"about_ca_topic_score_gemma":0.008303271,"teacher_disagreement_score":0.0039947876,"about_ca_system_score_codex":0.0011655171,"about_ca_system_score_gemma":0.0033878363,"threshold_uncertainty_score":0.013694882},"labels":[],"label_agreement":null},{"id":"W2076094047","doi":"10.1016/j.biologicals.2010.12.001","title":"The consistency approach for quality control of vaccines – A strategy to improve quality control and implement 3Rs","year":2011,"lang":"en","type":"article","venue":"Biologicals","topic":"Toxin Mechanisms and Immunotoxins","field":"Immunology and Microbiology","cited_by":81,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Joint Research Centre; Health Canada; European Commission","keywords":"Consistency (knowledge bases); Quality (philosophy); Harmonization; Risk analysis (engineering); Production (economics); Control (management); Product (mathematics); Computer science; Biotechnology; Quality management system; Biochemical engineering; Business; Engineering; Quality management; Mathematics; Marketing; Biology","score_opus":0.07057180977114384,"score_gpt":0.3179325884712634,"score_spread":0.24736077870011952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076094047","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.041370437,0.0036814169,0.9037731,0.018858926,0.001375147,0.0012028536,0.00026038554,0.0009934992,0.028484153],"genre_scores_gemma":[0.36174166,0.0017004971,0.6176619,0.006190535,0.00066672807,0.00076264975,0.0005142351,0.00038641854,0.010375301],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.94196594,0.023450961,0.0047141137,0.0048191934,0.023329824,0.0017200159],"domain_scores_gemma":[0.89080876,0.014404749,0.013544086,0.035460237,0.043836154,0.0019459852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.08478107,0.00083234033,0.0013716043,0.0032692247,0.0024750496,0.006384514,0.004615665,0.0034322191,0.003089821],"category_scores_gemma":[0.059134804,0.0008872362,0.0019946329,0.0019256959,0.0043817773,0.006472949,0.0050032693,0.0047382847,0.0011007116],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068941276,0.00085857406,0.020252313,0.0013486248,0.00049535173,0.00036963774,0.0017601869,0.01849774,0.072139286,0.43777955,0.016121114,0.42968822],"study_design_scores_gemma":[0.00049963896,0.003630293,0.022688078,0.0015621232,0.0006523037,0.0014806828,0.0017608253,0.08527455,0.2235403,0.3617979,0.29648805,0.0006252364],"about_ca_topic_score_codex":0.0047331178,"about_ca_topic_score_gemma":0.0038948283,"teacher_disagreement_score":0.08478107,"about_ca_system_score_codex":0.0063843206,"about_ca_system_score_gemma":0.016545037,"threshold_uncertainty_score":0.44837052},"labels":[],"label_agreement":null},{"id":"W2077952077","doi":"10.1016/j.biologicals.2011.09.005","title":"Biosimilars – Global issues, national solutions","year":2011,"lang":"en","type":"review","venue":"Biologicals","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Biosimilar; Biochemical engineering; Biotechnology; Biology; Engineering","score_opus":0.31092367599587706,"score_gpt":0.43790269373568413,"score_spread":0.12697901773980708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077952077","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011193826,0.10783922,0.002026471,0.8210725,0.020651273,0.000031597432,0.00023286499,0.00017129762,0.046855427],"genre_scores_gemma":[0.032824434,0.23238754,0.013994876,0.62372524,0.038848363,0.00015030493,0.0011823605,0.00044104666,0.056445844],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9919518,0.0019324096,0.00074444205,0.0011164236,0.0032834737,0.0009715125],"domain_scores_gemma":[0.98391366,0.0054902053,0.0014721823,0.001083412,0.004275342,0.0037651185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017912101,0.0010565097,0.0012603068,0.0019398291,0.0027507492,0.014056561,0.002394258,0.020566367,0.039116573],"category_scores_gemma":[0.017603055,0.0006089258,0.0011073406,0.0027905458,0.00635676,0.0295455,0.0076794126,0.016046861,0.012217825],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007166885,0.00016702518,0.00046249284,0.0011975097,0.00003084597,0.00039981757,0.0005647749,0.00034398536,0.0010698683,0.24928571,0.55303293,0.1933735],"study_design_scores_gemma":[0.000014287511,0.00004440132,0.0003711055,0.0006671619,0.000007768577,0.0004234372,0.0006091756,0.000114545,0.00014125266,0.04497485,0.9526149,0.00001713277],"about_ca_topic_score_codex":0.0015367519,"about_ca_topic_score_gemma":0.0018189255,"teacher_disagreement_score":0.039116573,"about_ca_system_score_codex":0.0048115104,"about_ca_system_score_gemma":0.015670907,"threshold_uncertainty_score":0.13085794},"labels":[],"label_agreement":null},{"id":"W2080125481","doi":"10.1006/biol.2001.0280","title":"A Quantitative Analysis for the ADP-Ribosylation Activity of Pertussis Toxin: An Enzymatic-HPLC Coupled Assay Applicable to Formulated Whole Cell and Acellular Pertussis Vaccine Products","year":2001,"lang":"en","type":"article","venue":"Biologicals","topic":"Antimicrobial Resistance in Staphylococcus","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Pertussis toxin; Bordetella pertussis; Biochemistry; ADP-ribosylation; NAD+ kinase; Peptide; Chemistry; Toxin; G protein; Enzyme; Molecular biology; Biology; Receptor; Bacteria","score_opus":0.04670270189066684,"score_gpt":0.31758877396226753,"score_spread":0.2708860720716007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080125481","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.33114716,0.0039897272,0.64742386,0.0003932008,0.0004398782,0.001404027,0.0034138574,0.0033515298,0.008436797],"genre_scores_gemma":[0.4691269,0.0035069075,0.49491283,0.0004829649,0.00018620223,0.0020544631,0.009075303,0.0006262984,0.020028109],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983392,0.0004540415,0.00011758485,0.00033713726,0.00058602437,0.00016598702],"domain_scores_gemma":[0.9984256,0.0006291885,0.00013941975,0.00027596368,0.00038342184,0.00014649334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012720968,0.0022098487,0.0010058121,0.0016676711,0.000686176,0.0008789703,0.0009231358,0.001060655,0.0017361192],"category_scores_gemma":[0.0017114482,0.0009777923,0.00072823954,0.0011977119,0.001059423,0.0006654537,0.00063641346,0.0028568928,0.002142655],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001303634,0.00008683106,0.00027197602,0.00006527094,0.000017006445,0.000023472094,0.000043636173,0.000111242436,0.99486935,0.0001591213,0.00009285191,0.0041289222],"study_design_scores_gemma":[0.000012524971,0.0002154692,0.001305407,0.000010021075,0.000030213505,0.00012688327,0.000014092387,0.0016599308,0.9953382,0.00005715249,0.0012188335,0.000011109183],"about_ca_topic_score_codex":0.002567178,"about_ca_topic_score_gemma":0.0044418317,"teacher_disagreement_score":0.002567178,"about_ca_system_score_codex":0.00082533696,"about_ca_system_score_gemma":0.0015745274,"threshold_uncertainty_score":0.0067275763},"labels":[],"label_agreement":null},{"id":"W2081733255","doi":"10.1016/j.biologicals.2009.11.010","title":"Influence of bovine serum albumin on the secondary structure of interferon alpha 2b as determined by far UV circular dichroism spectropolarimetry","year":2009,"lang":"en","type":"article","venue":"Biologicals","topic":"Protein purification and stability","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Health Canada","funders":"","keywords":"Circular dichroism; Protein secondary structure; Excipient; Bovine serum albumin; Chemistry; Protein tertiary structure; Alpha interferon; Albumin; Protein structure; Serum albumin; Alpha (finance); Chromatography; Interferon; Biochemistry; Immunology; Biology; Medicine; Surgery","score_opus":0.006941510629092174,"score_gpt":0.24706830781758232,"score_spread":0.24012679718849014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081733255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980774,0.0005208929,0.00074278604,0.00004074625,0.000021601758,0.000005371521,0.00004492821,0.000017502163,0.00052858156],"genre_scores_gemma":[0.998623,0.00016103826,0.00060479034,0.00004318154,0.00000771618,0.0000038135042,0.000084045,0.000019282645,0.0004532185],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999642,0.0001502983,0.000027973085,0.000044025808,0.00006861945,0.000067015884],"domain_scores_gemma":[0.9993693,0.000320991,0.00008622761,0.000043617754,0.00008794306,0.00009195861],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044425056,0.0003169215,0.00030872578,0.00015944694,0.0001907677,0.00045642053,0.00014721417,0.00021756494,0.0008363477],"category_scores_gemma":[0.00078597036,0.00017027961,0.0001929808,0.00015097311,0.00032328267,0.0001455025,0.00015091423,0.00032970106,0.0002840959],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064380467,0.00003089615,0.0003971335,0.00002046197,0.000009757964,0.000034820263,0.000028621453,0.00013118492,0.99796057,0.000025201054,0.000019140949,0.0006982934],"study_design_scores_gemma":[0.000016365884,0.0002923694,0.0024786603,0.0000029568203,0.000011794831,0.00004341586,0.00001620574,0.0008196841,0.9959416,0.00001494926,0.00035688642,0.000005084333],"about_ca_topic_score_codex":0.0018796675,"about_ca_topic_score_gemma":0.001371232,"teacher_disagreement_score":0.0018796675,"about_ca_system_score_codex":0.00030188583,"about_ca_system_score_gemma":0.0002476115,"threshold_uncertainty_score":0.0037375093},"labels":[],"label_agreement":null},{"id":"W2082256485","doi":"10.1016/j.biologicals.2013.09.002","title":"Neutralization of cobra venom by cocktail antiserum against venom proteins of cobra (Naja naja naja)","year":2013,"lang":"en","type":"article","venue":"Biologicals","topic":"Venomous Animal Envenomation and Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lakehead University","funders":"","keywords":"Venom; Naja; Antiserum; Neutralization; Biology; Antivenom; In vivo; Molecular biology; Antibody; Biochemistry; Immunology","score_opus":0.008960809197759838,"score_gpt":0.22084922252543082,"score_spread":0.21188841332767097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082256485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98668057,0.0018613706,0.006410672,0.00015158452,0.000117362426,0.00008927756,0.00012004252,0.00012598599,0.004443133],"genre_scores_gemma":[0.9838824,0.0013450481,0.0056353556,0.0001646959,0.000056038323,0.00007570417,0.0006904187,0.000031500615,0.00811876],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99978405,0.000027872027,0.00001919098,0.000054946937,0.000048331956,0.000065537664],"domain_scores_gemma":[0.999835,0.000032827666,0.000044449305,0.000024511937,0.000031023752,0.000032168173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025293947,0.00064558245,0.00029057637,0.0004051012,0.00036889233,0.00025357647,0.00028085156,0.00047011985,0.0017922284],"category_scores_gemma":[0.00019829175,0.0002798228,0.00046589403,0.00022078944,0.0002956593,0.00020098577,0.00033739477,0.00095800194,0.00046379486],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014981457,0.000043797936,0.000455768,0.000035524983,0.000015098217,0.00007150591,0.000033240813,0.000025060941,0.99800235,0.000113916954,0.000047003476,0.0010069915],"study_design_scores_gemma":[0.000031940883,0.0006826547,0.019094594,0.00002243998,0.00008098637,0.0009083842,0.000053757914,0.00071904593,0.97490466,0.00008191632,0.0034120788,0.000007592502],"about_ca_topic_score_codex":0.0011210088,"about_ca_topic_score_gemma":0.002101693,"teacher_disagreement_score":0.0017922284,"about_ca_system_score_codex":0.0003099739,"about_ca_system_score_gemma":0.0001968178,"threshold_uncertainty_score":0.0059955716},"labels":[],"label_agreement":null},{"id":"W2087287783","doi":"10.1016/j.biologicals.2007.11.004","title":"WHO informal consultation on regulatory evaluation of therapeutic biological medicinal products held at WHO Headquarters, Geneva, 19–20 April 2007","year":2008,"lang":"en","type":"article","venue":"Biologicals","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Biosimilar; Terminology; Innovator; Product (mathematics); Medicine; Business; Quality (philosophy); Regulatory science; Political science; Intellectual property; Law","score_opus":0.1320325286439629,"score_gpt":0.3391617240837612,"score_spread":0.20712919543979832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087287783","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022708537,0.027223153,0.007877112,0.77060896,0.05216991,0.0020203548,0.0038211313,0.0004923038,0.11307854],"genre_scores_gemma":[0.111305304,0.01143213,0.011159735,0.464667,0.017831871,0.0014681728,0.002328341,0.00067973457,0.3791278],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9898169,0.004605405,0.0007687282,0.00051081035,0.0022232225,0.0020748617],"domain_scores_gemma":[0.9837241,0.0077093374,0.0013093204,0.0004917529,0.0048409533,0.0019245077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017652325,0.0014394898,0.0009780253,0.0013437292,0.0051324917,0.0034697608,0.0021184403,0.023090534,0.018546335],"category_scores_gemma":[0.0174834,0.00074056594,0.001418102,0.0009351657,0.0027967081,0.0021067606,0.004083665,0.009818926,0.0037440914],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048678808,0.00010590043,0.001863794,0.0007013967,0.000044657252,0.0030802842,0.002792382,0.00020374487,0.008280401,0.003580463,0.95408845,0.024771832],"study_design_scores_gemma":[0.00010261408,0.00011659213,0.0036773463,0.00066160137,0.000052201784,0.0006092136,0.0025233028,0.00018713264,0.0028846827,0.0012293825,0.987899,0.00005693459],"about_ca_topic_score_codex":0.02314756,"about_ca_topic_score_gemma":0.03912709,"teacher_disagreement_score":0.02314756,"about_ca_system_score_codex":0.00615735,"about_ca_system_score_gemma":0.018745303,"threshold_uncertainty_score":0.09335548},"labels":[],"label_agreement":null},{"id":"W2088499232","doi":"10.1016/j.biologicals.2011.06.006","title":"Statistical considerations for confirmatory clinical trials for similar biotherapeutic products","year":2011,"lang":"en","type":"review","venue":"Biologicals","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"Health Canada","keywords":"Equivalence (formal languages); Clinical trial; Medicine; Product (mathematics); Computer science; Risk analysis (engineering); Mathematics; Pathology","score_opus":0.9821581373665009,"score_gpt":0.749156292279861,"score_spread":0.2330018450866399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088499232","genre_codex":"methods","genre_gemma":"review","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0037451566,0.095435575,0.80520827,0.03268659,0.01188969,0.03448206,0.0018269633,0.0011951071,0.013530622],"genre_scores_gemma":[0.0644194,0.019074198,0.8232755,0.013160533,0.0045617814,0.07212383,0.0008102376,0.0004269465,0.0021475365],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.2540111,0.6734051,0.036803976,0.0044853995,0.030513242,0.0007811661],"domain_scores_gemma":[0.107925005,0.8362222,0.018577484,0.021266887,0.015167838,0.00084064977],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.5530306,0.0023222852,0.009915822,0.0057113366,0.0013178311,0.0075604464,0.006009682,0.008799751,0.00925427],"category_scores_gemma":[0.7521966,0.0021279368,0.009342323,0.00851865,0.0072275097,0.00647398,0.002892073,0.013628269,0.0026174083],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012497421,0.00061793515,0.0034470388,0.10561284,0.012407003,0.001182963,0.0026141836,0.011542612,0.0020251828,0.20183055,0.05984881,0.58637345],"study_design_scores_gemma":[0.011037971,0.0059004715,0.0074064806,0.06476521,0.00737565,0.0021843994,0.0010760042,0.052387938,0.0046553235,0.523979,0.3186768,0.0005548105],"about_ca_topic_score_codex":0.0008024945,"about_ca_topic_score_gemma":0.0012026638,"teacher_disagreement_score":0.4469694,"about_ca_system_score_codex":0.0034979943,"about_ca_system_score_gemma":0.01109263,"threshold_uncertainty_score":0.5511929},"labels":[],"label_agreement":null},{"id":"W2089623432","doi":"10.1016/j.biologicals.2015.01.004","title":"Review of the current use and evaluation of cell substrates for producing biologicals in selected countries","year":2015,"lang":"en","type":"review","venue":"Biologicals","topic":"Medical Device Sterilization and Disinfection","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"World Health Organization","keywords":"China; Beijing; Political science; Medicine; Engineering management; Business; Library science; Computer science; Engineering","score_opus":0.20558237438473587,"score_gpt":0.4087074877431298,"score_spread":0.20312511335839395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089623432","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019341054,0.9983877,0.0001441489,0.00010280874,0.00016503318,0.000007908292,0.00004718109,0.0000066325,0.00094516954],"genre_scores_gemma":[0.0006569295,0.99835676,0.0002784919,0.00009475273,0.000097830925,0.000004986791,0.000049729075,0.0000012215274,0.00045925955],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999688,0.00004603959,0.00005440197,0.00004440989,0.00014322666,0.000023924145],"domain_scores_gemma":[0.99946636,0.00021827577,0.00012227113,0.0000133813965,0.00014111718,0.000038721904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070670125,0.0008877859,0.0011839264,0.0037716078,0.00023355879,0.0010912244,0.0008082141,0.0007460602,0.0038431464],"category_scores_gemma":[0.0010239634,0.00030676468,0.0005245794,0.0034328178,0.0002900613,0.0011733667,0.00060464855,0.0008296042,0.0013760463],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000095075906,0.00007990397,0.0002958276,0.045393266,0.00010706976,0.00022382903,0.00007602714,0.00035467115,0.0044365176,0.0020621072,0.027238218,0.9196375],"study_design_scores_gemma":[0.000012121062,0.0001509814,0.0012546604,0.005590427,0.00017340654,0.0010132348,0.00007198343,0.00008539403,0.0012882345,0.00071392505,0.98962235,0.000023365275],"about_ca_topic_score_codex":0.0013048422,"about_ca_topic_score_gemma":0.0024866716,"teacher_disagreement_score":0.0038431464,"about_ca_system_score_codex":0.0005028009,"about_ca_system_score_gemma":0.0014483809,"threshold_uncertainty_score":0.012856662},"labels":[],"label_agreement":null},{"id":"W2097551778","doi":"10.1016/j.biologicals.2012.03.003","title":"Evaluation of a candidate International Standard for Meningococcal Group C polysaccharide","year":2012,"lang":"en","type":"article","venue":"Biologicals","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Health Canada","keywords":"Meningococcal vaccine; Neisseria meningitidis; Chemistry; Chromatography; Biology","score_opus":0.23618787003599698,"score_gpt":0.47472832979962504,"score_spread":0.23854045976362806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097551778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91955245,0.00469643,0.04807561,0.0015984109,0.00071342476,0.0029065243,0.0009170559,0.0002514392,0.02128876],"genre_scores_gemma":[0.92591536,0.0011422578,0.0651775,0.0008533059,0.00014466018,0.0011578694,0.0019949106,0.00005266044,0.0035613258],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9912253,0.005358272,0.00060253637,0.00048456545,0.0020128158,0.00031650517],"domain_scores_gemma":[0.98944294,0.003146433,0.0011617308,0.0011511313,0.004361644,0.0007360937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018447455,0.00064665487,0.0004716383,0.0015111263,0.00095468666,0.0014412784,0.0015205077,0.001596508,0.002848483],"category_scores_gemma":[0.016858676,0.00021250933,0.00055947545,0.000841127,0.0010822435,0.0008043901,0.00097343157,0.0009133353,0.0006552047],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026090438,0.008730696,0.072792195,0.0015509219,0.00033596216,0.00029826313,0.0022328305,0.004094001,0.5356681,0.019817157,0.0064875847,0.32190192],"study_design_scores_gemma":[0.0022685926,0.114602655,0.09966604,0.000561849,0.0007156374,0.00088528544,0.0030434276,0.008220241,0.70227754,0.0033078701,0.06433809,0.000112822076],"about_ca_topic_score_codex":0.0018641134,"about_ca_topic_score_gemma":0.0016206253,"teacher_disagreement_score":0.018447455,"about_ca_system_score_codex":0.001971782,"about_ca_system_score_gemma":0.0035543242,"threshold_uncertainty_score":0.097560644},"labels":[],"label_agreement":null},{"id":"W2100520373","doi":"10.1016/j.biologicals.2011.02.001","title":"Three Rs approaches in the production and quality control of fish vaccines","year":2011,"lang":"en","type":"article","venue":"Biologicals","topic":"Aquaculture disease management and microbiota","field":"Immunology and Microbiology","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada); Health Canada; Canadian Council on Animal Care","funders":"","keywords":"Quality (philosophy); Fish <Actinopterygii>; Vaccination; Animal welfare; Business; Production (economics); Biotechnology; Control (management); Animal testing; Risk analysis (engineering); Toxicology; Computer science; Medicine; Biology; Fishery; Immunology; Ecology","score_opus":0.1164029874476921,"score_gpt":0.2631066938941076,"score_spread":0.1467037064464155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100520373","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3303902,0.04282517,0.56237537,0.0072870073,0.0011385543,0.001105449,0.00031863674,0.0010909114,0.05346872],"genre_scores_gemma":[0.7136893,0.0135879535,0.23994567,0.0016444277,0.00032535937,0.00060385396,0.00020862494,0.00013945214,0.029855331],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.997375,0.00067896425,0.00020868632,0.0003624822,0.0011330179,0.00024194397],"domain_scores_gemma":[0.999012,0.00018945966,0.00024865815,0.00026689927,0.00019905329,0.00008398719],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051637297,0.0009860538,0.00073469226,0.0015895617,0.0007090012,0.0035976018,0.001474343,0.0015023728,0.0028596108],"category_scores_gemma":[0.0021071557,0.0004764757,0.0017522967,0.00068301335,0.002045359,0.0018523064,0.0021017871,0.0019003755,0.0012023271],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011538168,0.0006242982,0.0027818019,0.0009345639,0.00017269189,0.00019925548,0.00035638944,0.006272783,0.6366385,0.070841126,0.0010283763,0.27899635],"study_design_scores_gemma":[0.00021039236,0.00554133,0.0046668597,0.0002195005,0.00033187206,0.0007107074,0.000429848,0.012752494,0.8881879,0.021947043,0.064869136,0.0001329691],"about_ca_topic_score_codex":0.0011196091,"about_ca_topic_score_gemma":0.0010909443,"teacher_disagreement_score":0.0051637297,"about_ca_system_score_codex":0.0017960191,"about_ca_system_score_gemma":0.0013026543,"threshold_uncertainty_score":0.027308762},"labels":[],"label_agreement":null},{"id":"W2120786830","doi":"10.1016/j.biologicals.2005.06.007","title":"The effect of solvent environment on the conformation and stability of human polyclonal IgG in solution","year":2005,"lang":"en","type":"article","venue":"Biologicals","topic":"Protein purification and stability","field":"Biochemistry, Genetics and Molecular Biology","cited_by":75,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Prairie Oat Growers Association; Agence Nationale pour la Gestion des Déchets Radioactifs; Hungarian Scientific Research Fund; Teva Pharmaceutical Industries","keywords":"Sorbitol; Chemistry; Conformational change; Denaturation (fissile materials); Maltose; Monomer; Thermal stability; Solvent; Sucrose; Biophysics; Chromatography; Organic chemistry; Biochemistry; Polymer; Nuclear chemistry","score_opus":0.0167142682739987,"score_gpt":0.25720191343629795,"score_spread":0.24048764516229926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120786830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977064,0.0007116898,0.00085665024,0.0000591392,0.000016810944,0.0000040660607,0.000061463674,0.00001280994,0.0005710114],"genre_scores_gemma":[0.9984174,0.00036528383,0.00048725883,0.000036960784,0.000010291534,0.0000050801914,0.00014966051,0.000018256998,0.0005098251],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998186,0.00005386892,0.000013888963,0.00003343407,0.000039210623,0.000040892923],"domain_scores_gemma":[0.9994493,0.0003170166,0.000060545353,0.000036908765,0.0000649889,0.000071326125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039840426,0.00024873542,0.0001802611,0.00011475794,0.00022124968,0.00038082548,0.00020865617,0.00020230412,0.001066511],"category_scores_gemma":[0.0008136867,0.00015885252,0.00016264427,0.00016729184,0.00039574847,0.00038426736,0.0001584261,0.00039704973,0.00021629583],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008618502,0.000033256543,0.0011767665,0.00004829919,0.000019457177,0.00009042635,0.00007909686,0.00027673022,0.9946731,0.00012344244,0.00006761592,0.0025500455],"study_design_scores_gemma":[0.000023323433,0.00025875462,0.003285678,0.0000039773768,0.000015197805,0.0001321869,0.000031609765,0.0009357589,0.99481493,0.00006336539,0.00042620677,0.00000903648],"about_ca_topic_score_codex":0.0010675107,"about_ca_topic_score_gemma":0.0010241518,"teacher_disagreement_score":0.0010675107,"about_ca_system_score_codex":0.00027378273,"about_ca_system_score_gemma":0.00030356526,"threshold_uncertainty_score":0.0035678148},"labels":[],"label_agreement":null},{"id":"W2124287269","doi":"10.1016/j.biologicals.2012.07.005","title":"Report on the international workshop on alternative methods for human and veterinary rabies vaccine testing: State of the science and planning the way forward","year":2012,"lang":"en","type":"article","venue":"Biologicals","topic":"Rabies epidemiology and control","field":"Immunology and Microbiology","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Rabies; Potency; Rabies virus; Rabies vaccine; Medicine; Vaccination; Veterinary medicine; Virology; Test (biology); Human use; Biotechnology; Biology; In vitro","score_opus":0.1690479999700361,"score_gpt":0.41720956290237615,"score_spread":0.24816156293234004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124287269","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019407105,0.11287373,0.033914994,0.46221048,0.29351276,0.0037286966,0.005811461,0.00053823984,0.06800247],"genre_scores_gemma":[0.08062395,0.075474955,0.0504577,0.20791116,0.09161237,0.0038058702,0.013034078,0.0009334446,0.4761465],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9924615,0.0019732877,0.00051960506,0.0006887319,0.0030391582,0.0013177306],"domain_scores_gemma":[0.9806368,0.003949208,0.0012322816,0.0006169879,0.009394945,0.0041698124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02655709,0.0026787543,0.001407256,0.0015884317,0.002369645,0.0067324373,0.004314057,0.015610195,0.029540444],"category_scores_gemma":[0.012281313,0.0008002704,0.0029763824,0.0008780637,0.0018280639,0.005003243,0.004273233,0.012012562,0.009011737],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014802006,0.0011289868,0.0038632676,0.0018659061,0.00022187819,0.001143664,0.00062966853,0.0011695684,0.013076739,0.0048562842,0.8396287,0.13093515],"study_design_scores_gemma":[0.00009903662,0.0005493022,0.0042625475,0.00042356813,0.00011775064,0.00026269196,0.0008254024,0.00031691234,0.005645418,0.0021583943,0.98522854,0.00011044804],"about_ca_topic_score_codex":0.009818334,"about_ca_topic_score_gemma":0.012671224,"teacher_disagreement_score":0.029540444,"about_ca_system_score_codex":0.0025754622,"about_ca_system_score_gemma":0.010207546,"threshold_uncertainty_score":0.14044899},"labels":[],"label_agreement":null},{"id":"W2173702989","doi":"10.1016/j.biologicals.2015.09.001","title":"Reverse vaccinology as an approach for developing Histophilus somni vaccine candidates","year":2015,"lang":"en","type":"article","venue":"Biologicals","topic":"Microbial infections and disease research","field":"Immunology and Microbiology","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health; University of Saskatchewan","funders":"Alberta Livestock and Meat Agency","keywords":"Reverse vaccinology; Biology; Genome; Antigen; Antigenicity; Microbiology; Bacteria; Whole genome sequencing; Pathogen; Vaccination; Gene; Virology; Computational biology; Genetics","score_opus":0.08899190730983174,"score_gpt":0.3403462491360139,"score_spread":0.25135434182618216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2173702989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.73249006,0.034846246,0.19882737,0.003887113,0.0021565491,0.0014676984,0.00082854764,0.00068107527,0.024815336],"genre_scores_gemma":[0.91147333,0.01581488,0.060733967,0.0007370723,0.00024587632,0.00038355132,0.0006235713,0.00007085655,0.009916984],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99982244,0.000053530206,0.000010560806,0.000025613235,0.000045197914,0.000042621217],"domain_scores_gemma":[0.99982953,0.000044358527,0.000038369635,0.000027337932,0.000039094182,0.000021240203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065974856,0.00067201623,0.00043032444,0.0003970299,0.00022751685,0.0006866042,0.00057984126,0.00064053125,0.0019413603],"category_scores_gemma":[0.00040966467,0.00026044084,0.00045996945,0.00015645842,0.00049675774,0.00057057367,0.00036263347,0.0019810144,0.0006647301],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033812897,0.0002906174,0.0004972924,0.00030998825,0.000024903064,0.0001583206,0.000046891913,0.0011062339,0.95892525,0.006618413,0.0006107189,0.031073276],"study_design_scores_gemma":[0.00018604366,0.0049304944,0.0009063962,0.000065207394,0.00010731951,0.0009432386,0.00010535042,0.0036971567,0.95742255,0.0030529383,0.028559016,0.00002432754],"about_ca_topic_score_codex":0.0003274101,"about_ca_topic_score_gemma":0.00045446426,"teacher_disagreement_score":0.0019413603,"about_ca_system_score_codex":0.00041256443,"about_ca_system_score_gemma":0.00044096867,"threshold_uncertainty_score":0.0064944625},"labels":[],"label_agreement":null},{"id":"W2302865716","doi":"10.1016/j.biologicals.2016.02.001","title":"Support for the revocation of general safety test regulations in biologics license applications","year":2016,"lang":"en","type":"article","venue":"Biologicals","topic":"Immunotoxicology and immune responses","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"Pfizer","keywords":"Adjuvant; Toxicity; Food and drug administration; Pharmacology; Medicine; Test (biology); Immune system; Biology; Immunology; Internal medicine","score_opus":0.02577668538105677,"score_gpt":0.2891273630291305,"score_spread":0.26335067764807374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2302865716","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.093399025,0.0035663305,0.03365162,0.5244005,0.020041594,0.0021881599,0.0022681637,0.00652836,0.31395638],"genre_scores_gemma":[0.29689038,0.0019031978,0.030046761,0.46066776,0.0057835253,0.0013750662,0.0024129516,0.0008664993,0.20005381],"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.95287627,0.009557457,0.0045151566,0.004035809,0.0228503,0.0061649345],"domain_scores_gemma":[0.7163168,0.15353048,0.014518444,0.015845314,0.08757622,0.012212716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.059570573,0.0008244841,0.001025443,0.0027496323,0.0043382607,0.0074037537,0.0070978,0.030879121,0.026552979],"category_scores_gemma":[0.13542932,0.0009053723,0.0035576865,0.0012449552,0.00489175,0.004260227,0.0038829327,0.01782174,0.008486347],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009844615,0.0019153662,0.024883753,0.0014549155,0.00028410615,0.0036763474,0.0022319462,0.0033281408,0.048302047,0.15965483,0.61880374,0.13448033],"study_design_scores_gemma":[0.00048262152,0.0013018968,0.034971762,0.0014627803,0.00030804874,0.002581793,0.0015729788,0.0038749764,0.02267286,0.017212398,0.91326576,0.0002921572],"about_ca_topic_score_codex":0.015611555,"about_ca_topic_score_gemma":0.01916039,"teacher_disagreement_score":0.059570573,"about_ca_system_score_codex":0.0061315885,"about_ca_system_score_gemma":0.03687648,"threshold_uncertainty_score":0.31504303},"labels":[],"label_agreement":null},{"id":"W2342581896","doi":"10.1016/j.biologicals.2016.03.006","title":"Switching to biosimilar infliximab (CT-P13): Evidence of clinical safety, effectiveness and impact on public health","year":2016,"lang":"en","type":"review","venue":"Biologicals","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biosimilar; Infliximab; Medicine; Public health; Intensive care medicine; Internal medicine; Pathology; Disease","score_opus":0.3128732576127962,"score_gpt":0.5311404830159735,"score_spread":0.21826722540317728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2342581896","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019780386,0.99868757,0.00005828659,0.0003906549,0.00009129708,0.0000035399482,0.000013766732,0.0000017736891,0.0005552699],"genre_scores_gemma":[0.0020800817,0.99729115,0.0001346319,0.00025972392,0.000071644514,0.0000047855997,0.000019829195,9.90287e-7,0.00013720994],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99874085,0.00035566816,0.00026490013,0.00016197083,0.00041863095,0.000057986144],"domain_scores_gemma":[0.99602413,0.0027720232,0.00054079824,0.0000586295,0.00053652097,0.00006780261],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002543383,0.0005333371,0.0014716617,0.0018083078,0.00021576048,0.0013008615,0.00060479407,0.0014986313,0.0028169388],"category_scores_gemma":[0.004899372,0.00023731105,0.0009823022,0.001763652,0.00050735596,0.0010415149,0.0005252916,0.0012992623,0.0006599007],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017083077,0.00005952878,0.00038687844,0.075231306,0.00040029222,0.0002017458,0.00012243974,0.00023154326,0.0019442528,0.0031832193,0.009329931,0.90873814],"study_design_scores_gemma":[0.00008608117,0.00056055427,0.003436291,0.067765325,0.00192768,0.0034194014,0.0003743806,0.00016317461,0.0030083316,0.0032140687,0.915987,0.00005767621],"about_ca_topic_score_codex":0.0009938087,"about_ca_topic_score_gemma":0.001582528,"teacher_disagreement_score":0.0028169388,"about_ca_system_score_codex":0.0007227513,"about_ca_system_score_gemma":0.0024996805,"threshold_uncertainty_score":0.013450921},"labels":[],"label_agreement":null},{"id":"W2440811431","doi":"10.1016/j.biologicals.2016.04.007","title":"Where are we in our understanding of the association between narcolepsy and one of the 2009 adjuvanted influenza A (H1N1) vaccines?","year":2016,"lang":"en","type":"article","venue":"Biologicals","topic":"Sleep and Wakefulness Research","field":"Neuroscience","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"World Health Organization","keywords":"Narcolepsy; Pandemic; Medicine; Influenza vaccine; Epidemiology; Vaccination; Cataplexy; H1N1 influenza; Adverse effect; Immunology; Family medicine; Coronavirus disease 2019 (COVID-19); Psychiatry; Modafinil; Internal medicine; Disease","score_opus":0.17655188406803426,"score_gpt":0.3462955659315847,"score_spread":0.16974368186355046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2440811431","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017897524,0.65434813,0.005204092,0.3139617,0.0041606897,0.000045053166,0.0005657072,0.00008672125,0.0037303295],"genre_scores_gemma":[0.14489642,0.67969984,0.010664047,0.1335705,0.028011777,0.00016787407,0.0005373615,0.00007059008,0.0023815192],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99763024,0.0009955671,0.0003910035,0.0003330375,0.00035238455,0.0002976746],"domain_scores_gemma":[0.97710174,0.013222857,0.0034861516,0.0009644345,0.0039168224,0.0013079336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016346522,0.0009945845,0.0041864524,0.0014898153,0.0016542501,0.005979721,0.0032698915,0.0076190326,0.0048563275],"category_scores_gemma":[0.018978268,0.0009646198,0.0019082696,0.0013803225,0.0042471997,0.016346062,0.0024552203,0.012456844,0.0016876335],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045124483,0.0018188237,0.13678928,0.016394094,0.005304469,0.0036019355,0.0049042576,0.0034292706,0.020402385,0.055160988,0.11890704,0.628775],"study_design_scores_gemma":[0.0005010601,0.0018792532,0.14022568,0.027279941,0.003911705,0.0064379866,0.024800727,0.0055008023,0.003456812,0.294042,0.4909243,0.0010398908],"about_ca_topic_score_codex":0.012741096,"about_ca_topic_score_gemma":0.017850142,"teacher_disagreement_score":0.016346522,"about_ca_system_score_codex":0.001850869,"about_ca_system_score_gemma":0.0054434966,"threshold_uncertainty_score":0.08644974},"labels":[],"label_agreement":null},{"id":"W2496582177","doi":"10.1016/j.biologicals.2016.06.002","title":"Report of the International Regulatory Forum on Human Cell Therapy and Gene Therapy Products","year":2016,"lang":"en","type":"article","venue":"Biologicals","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"Japan Agency for Medical Research and Development","keywords":"Regulatory agency; Agency (philosophy); Quality (philosophy); Regulatory science; Regulatory authority; Business; Political science; Medicine; Public relations; Public administration; Pathology; Sociology","score_opus":0.08972948811793831,"score_gpt":0.33040383325975975,"score_spread":0.24067434514182146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2496582177","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020808024,0.020186478,0.014072702,0.63695306,0.10977974,0.0017961578,0.0038781676,0.00069308636,0.19183257],"genre_scores_gemma":[0.085678205,0.009078668,0.014448224,0.5131939,0.030241327,0.0029121086,0.0028318276,0.00055981707,0.3410559],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9733234,0.0051314207,0.0013949414,0.0016718548,0.012717552,0.0057609286],"domain_scores_gemma":[0.9704626,0.017715724,0.0019420332,0.0011483391,0.004748559,0.003982758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04089164,0.0025800536,0.001617707,0.0027612152,0.0066613765,0.010834171,0.0037765845,0.06683952,0.0100759985],"category_scores_gemma":[0.036221754,0.001190538,0.0042972653,0.001683905,0.004012467,0.0050758985,0.005766878,0.032048464,0.0022849448],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039886285,0.00075147086,0.0020657715,0.00066121836,0.000093167844,0.0020411224,0.0019564284,0.001017208,0.0053247586,0.09003034,0.8726074,0.02305225],"study_design_scores_gemma":[0.00012273676,0.00018669039,0.0050471635,0.0005852858,0.00012280911,0.00033620524,0.0010853905,0.0005904295,0.0033135435,0.008690923,0.9798045,0.00011430519],"about_ca_topic_score_codex":0.02588061,"about_ca_topic_score_gemma":0.03108249,"teacher_disagreement_score":0.06683952,"about_ca_system_score_codex":0.0064608483,"about_ca_system_score_gemma":0.03600748,"threshold_uncertainty_score":0.21625823},"labels":[],"label_agreement":null},{"id":"W2592281295","doi":"10.1016/j.biologicals.2017.01.006","title":"The impact of oxidative DNA changes and ATM expression on morphological and functional activities on hepatocytes obtained from mesenchymal stem cells","year":2017,"lang":"en","type":"article","venue":"Biologicals","topic":"Carcinogens and Genotoxicity Assessment","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nutrasource","funders":"Iran National Science Foundation","keywords":"Mesenchymal stem cell; Cell biology; Cellular differentiation; Oxidative phosphorylation; Biology; Reactive oxygen species; Stem cell; Progenitor cell; Molecular biology; Chemistry; Biochemistry; Gene","score_opus":0.039182796231659135,"score_gpt":0.29635522549772214,"score_spread":0.257172429266063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592281295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962547,0.000585529,0.0012104706,0.000042543477,0.000021183947,0.000011824864,0.00030616816,0.00001520854,0.0015524789],"genre_scores_gemma":[0.9965585,0.00035315225,0.0005591065,0.000040855786,0.000005235134,0.00001687746,0.00043097467,0.0000061388064,0.0020291659],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998678,0.000026213225,0.000019892468,0.000023857012,0.00003203281,0.000030168101],"domain_scores_gemma":[0.99992514,0.000019215593,0.000013653224,0.000008303645,0.000016323387,0.000017303792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012248382,0.00021197749,0.00013838954,0.00019977751,0.00013778018,0.00022023373,0.000098487726,0.00017228778,0.0015617633],"category_scores_gemma":[0.00009025999,0.0001051653,0.00026014898,0.00016764602,0.00018609886,0.00018581233,0.00014448329,0.000290261,0.00022929345],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025933998,0.000022358965,0.00095275784,0.000027220474,0.000008404842,0.00007862201,0.000031757983,0.000041509593,0.99738306,0.00006943359,0.000012683735,0.0011128377],"study_design_scores_gemma":[0.0000070126284,0.00028256272,0.013746852,0.000002452116,0.00002597266,0.00014584516,0.00008148438,0.00017450971,0.98459125,0.00003544112,0.0009027489,0.0000038863122],"about_ca_topic_score_codex":0.00069719343,"about_ca_topic_score_gemma":0.0010177545,"teacher_disagreement_score":0.0015617633,"about_ca_system_score_codex":0.000109485096,"about_ca_system_score_gemma":0.00014750642,"threshold_uncertainty_score":0.0052245855},"labels":[],"label_agreement":null},{"id":"W2622615271","doi":"10.1016/j.biologicals.2017.05.006","title":"Modern science for better quality control of medicinal products “Towards global harmonization of 3Rs in biologicals”: The report of an EPAA workshop","year":2017,"lang":"en","type":"article","venue":"Biologicals","topic":"Diphtheria, Corynebacterium, and Tetanus","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"Joint Research Centre; Directorate-General for the Environment; European Federation of Pharmaceutical Industries and Associations; World Health Organization; National Centre for the Replacement Refinement and Reduction of Animals in Research; European Commission; European Partnership for Alternative Approaches to Animal Testing","keywords":"Harmonization; Good laboratory practice; Quality (philosophy); General partnership; Business; Agency (philosophy); Biotechnology; Medicine; Political science; Quality assurance; Marketing; Biology; Law","score_opus":0.06057264648608483,"score_gpt":0.3716940175364104,"score_spread":0.31112137105032556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2622615271","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.052096594,0.08938349,0.12391022,0.6155442,0.040600378,0.0045268284,0.0012407656,0.0005558777,0.072141714],"genre_scores_gemma":[0.32638568,0.08066532,0.20137104,0.26303858,0.018819373,0.0057636364,0.0039928267,0.0011282566,0.09883532],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.96247417,0.017703932,0.0022262044,0.0024737008,0.011131903,0.0039900728],"domain_scores_gemma":[0.97839147,0.006544139,0.0022475182,0.0025284544,0.007290127,0.0029982303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.08650012,0.0020440056,0.0011414917,0.0016151682,0.0030400774,0.0074659027,0.0034596962,0.012754515,0.006202771],"category_scores_gemma":[0.021860417,0.0008904668,0.0040842025,0.0011917788,0.0046863817,0.007453535,0.014199274,0.0135469,0.001919349],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010549914,0.002833775,0.003086192,0.006530976,0.0004302916,0.0028590804,0.013035161,0.009513384,0.07994583,0.13762255,0.3803804,0.3627074],"study_design_scores_gemma":[0.00012661461,0.0007566574,0.0026666084,0.0011495511,0.00008019002,0.00060884305,0.002086315,0.0010953877,0.023463856,0.0262863,0.9415386,0.00014103492],"about_ca_topic_score_codex":0.0022249466,"about_ca_topic_score_gemma":0.0020835467,"teacher_disagreement_score":0.08650012,"about_ca_system_score_codex":0.0054520485,"about_ca_system_score_gemma":0.02469654,"threshold_uncertainty_score":0.45746183},"labels":[],"label_agreement":null},{"id":"W2625442506","doi":"10.1016/j.biologicals.2017.06.001","title":"A demonstration of analytical similarity comparing a proposed biosimilar pegfilgrastim and reference pegfilgrastim","year":2017,"lang":"en","type":"article","venue":"Biologicals","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Apotex (Canada)","funders":"","keywords":"Pegfilgrastim; Biosimilar; Similarity (geometry); Medicine; Computer science; Pharmacology; Filgrastim; Internal medicine; Artificial intelligence; Granulocyte colony-stimulating factor; Chemotherapy","score_opus":0.14107235592230905,"score_gpt":0.3735971690895813,"score_spread":0.23252481316727225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2625442506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9593446,0.00068202807,0.036085,0.00015888577,0.00004023465,0.00015337708,0.00028790036,0.0000957826,0.0031521458],"genre_scores_gemma":[0.97997254,0.00025884705,0.018440466,0.00011648697,0.000024207164,0.00007280189,0.0003910711,0.000022764805,0.0007008384],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988961,0.00018863688,0.00006555144,0.00017895192,0.00060200994,0.00006875427],"domain_scores_gemma":[0.9987299,0.00037438385,0.00038409815,0.00011182895,0.00032013984,0.00007962552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088217505,0.0003503873,0.00016132322,0.00061389187,0.00023256995,0.0004743607,0.00047503333,0.0005613669,0.0013521584],"category_scores_gemma":[0.0026857913,0.00011658979,0.00036554402,0.00041691633,0.0005868023,0.00036920703,0.00045414685,0.00078503427,0.00036233902],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002901435,0.00013729125,0.0013163511,0.00005638819,0.000019736644,0.00008223194,0.000083184445,0.0003056896,0.9897278,0.00044148983,0.00008471379,0.007455063],"study_design_scores_gemma":[0.00003902319,0.0016041875,0.009362266,0.000012631047,0.000044215358,0.001303223,0.00007279015,0.005532502,0.97847545,0.00032901193,0.0032091413,0.000015534539],"about_ca_topic_score_codex":0.00038566522,"about_ca_topic_score_gemma":0.00029647732,"teacher_disagreement_score":0.0013521584,"about_ca_system_score_codex":0.00038821172,"about_ca_system_score_gemma":0.00052469136,"threshold_uncertainty_score":0.0046654344},"labels":[],"label_agreement":null},{"id":"W2779036013","doi":"10.1016/j.biologicals.2017.12.002","title":"WHO informal consultation on development of guidelines on procedures and data requirements for changes to approved biotherapeutic products, Seoul, Republic of Korea, 27–28 April 2017","year":2017,"lang":"en","type":"article","venue":"Biologicals","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"Ministry of Food and Drug Safety; World Health Organization","keywords":"Harmonization; Standardization; Authorization; Licensure; Business; Quality (philosophy); Medicine; Public consultation; Medical education; Computer science; Engineering; Computer security","score_opus":0.3204473695739347,"score_gpt":0.4391512621598847,"score_spread":0.11870389258594999,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2779036013","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.025069652,0.013137526,0.02577731,0.57226336,0.038337484,0.0067711016,0.010965709,0.0025942933,0.30508348],"genre_scores_gemma":[0.062214248,0.007555909,0.035170652,0.25564408,0.0050218436,0.0031198263,0.0060200635,0.0012799444,0.6239734],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9945739,0.0022571185,0.0009445526,0.00033272945,0.0010845348,0.00080721395],"domain_scores_gemma":[0.9865773,0.00460313,0.0010017107,0.00069462945,0.005958586,0.0011647985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01449496,0.0006934475,0.0004119802,0.0016132264,0.0024916313,0.0019932997,0.001018516,0.0057918276,0.053374175],"category_scores_gemma":[0.023105748,0.000586255,0.0007837031,0.00064244727,0.0013044712,0.0017807971,0.0032841023,0.004370199,0.019232856],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001497648,0.00013725445,0.0014894076,0.00031856465,0.000016435457,0.0010488839,0.0015372758,0.00009919678,0.003090224,0.0019262966,0.945413,0.04477373],"study_design_scores_gemma":[0.00004063509,0.000029387926,0.0012807224,0.0002852305,0.000014708257,0.00026513886,0.0013607319,0.00010281074,0.0012837171,0.00058535376,0.9947272,0.000024496712],"about_ca_topic_score_codex":0.015066194,"about_ca_topic_score_gemma":0.03651183,"teacher_disagreement_score":0.053374175,"about_ca_system_score_codex":0.003439694,"about_ca_system_score_gemma":0.013936799,"threshold_uncertainty_score":0.17855442},"labels":[],"label_agreement":null},{"id":"W2806244397","doi":"10.1016/j.biologicals.2018.05.006","title":"Host cell protein testing strategy for hepatitis B antigen in Hexavalent vaccine – Towards a general testing strategy for recombinant vaccines","year":2018,"lang":"en","type":"article","venue":"Biologicals","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada)","funders":"","keywords":"Virology; Recombinant DNA; Antigen; Biology; Immunology; Gene; Biochemistry","score_opus":0.15399945393424844,"score_gpt":0.35258786534686404,"score_spread":0.1985884114126156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2806244397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.54072714,0.0030172034,0.44168448,0.00095234875,0.00013725813,0.0011021014,0.00034437716,0.0007265236,0.011308564],"genre_scores_gemma":[0.84226584,0.0017974153,0.14503783,0.0005366185,0.000044959146,0.00045508618,0.00051964744,0.00010726077,0.0092353225],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991906,0.00024763195,0.00004874386,0.0001589194,0.00024215937,0.00011199263],"domain_scores_gemma":[0.99960977,0.00009814483,0.000049991322,0.00007007008,0.00012652877,0.000045431618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011314157,0.0009907066,0.0005944077,0.00086503674,0.0003973837,0.0007898946,0.0009739431,0.00089195586,0.0015940873],"category_scores_gemma":[0.0006046705,0.00039806866,0.0005085643,0.00030646066,0.0008592956,0.0009898169,0.0009940591,0.0010976754,0.0008366446],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000104104394,0.00008384639,0.0005867136,0.000086696265,0.000008963689,0.000119815195,0.00008556986,0.00058403146,0.9877637,0.001808732,0.000094749994,0.008673113],"study_design_scores_gemma":[0.000014836614,0.000919357,0.00049405836,0.000010612729,0.000024659055,0.00035012842,0.00006776001,0.0049257125,0.989363,0.0012430521,0.0025735951,0.000013206092],"about_ca_topic_score_codex":0.0006468842,"about_ca_topic_score_gemma":0.0006041491,"teacher_disagreement_score":0.0015940873,"about_ca_system_score_codex":0.00052392273,"about_ca_system_score_gemma":0.00064842025,"threshold_uncertainty_score":0.005983591},"labels":[],"label_agreement":null},{"id":"W2809322123","doi":"10.1016/j.biologicals.2018.06.001","title":"First evaluation of endotoxins in veterinary autogenous vaccines produced in Italy by LAL assay","year":2018,"lang":"en","type":"article","venue":"Biologicals","topic":"Microbial infections and disease research","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Health, British Columbia","keywords":"Veterinary medicine; Medicine; Microbiology; Biology","score_opus":0.07382721005317615,"score_gpt":0.3508914496349961,"score_spread":0.2770642395818199,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809322123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988177,0.0014134847,0.0062700426,0.00015244306,0.00007353472,0.000120815814,0.0003456961,0.00008435791,0.0033625849],"genre_scores_gemma":[0.99207085,0.00044600008,0.0042003593,0.00009614745,0.000044393495,0.00008167994,0.0007698052,0.000022522045,0.0022683453],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991098,0.00039722832,0.000039862007,0.00011809203,0.00021148588,0.00012342582],"domain_scores_gemma":[0.99938726,0.000140015,0.00015415082,0.00009592404,0.00015976604,0.00006280961],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088851363,0.00072028284,0.00039078936,0.00052553124,0.00024111853,0.0004137673,0.0002793635,0.0005484554,0.0012941825],"category_scores_gemma":[0.0009161025,0.00014939415,0.0005326721,0.0003527445,0.0004960383,0.0002528322,0.00044925808,0.0006809047,0.00060025457],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012925996,0.0002952846,0.00854905,0.00013326018,0.000030003239,0.00013316149,0.00018649618,0.00032404764,0.9741784,0.00017155324,0.0002178684,0.014488404],"study_design_scores_gemma":[0.00009748915,0.015073403,0.056725577,0.00004358496,0.0001254003,0.00036354607,0.0002375084,0.00091282325,0.91969633,0.00020978841,0.006494621,0.00001987056],"about_ca_topic_score_codex":0.00048175256,"about_ca_topic_score_gemma":0.0004341783,"teacher_disagreement_score":0.0012941825,"about_ca_system_score_codex":0.00045648558,"about_ca_system_score_gemma":0.00028924827,"threshold_uncertainty_score":0.004698932},"labels":[],"label_agreement":null},{"id":"W2886053403","doi":"10.1016/j.biologicals.2018.08.002","title":"Report of the international conference on next generation sequencing for adventitious virus detection in biologicals","year":2018,"lang":"en","type":"article","venue":"Biologicals","topic":"Animal Virus Infections Studies","field":"Agricultural and Biological Sciences","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"World Health Organization","keywords":"Standardization; Harmonization; Food and drug administration; Biotechnology; Product (mathematics); Medicine; Risk analysis (engineering); Computer science; Biology","score_opus":0.24971553877288072,"score_gpt":0.31916708154652623,"score_spread":0.06945154277364551,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886053403","genre_codex":"methods","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.116230056,0.14860457,0.29281002,0.10987285,0.13480312,0.0056972206,0.020936027,0.0031995652,0.16784649],"genre_scores_gemma":[0.19483961,0.075320564,0.20580608,0.02563022,0.023780912,0.002932557,0.047664355,0.0021160098,0.42190966],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959409,0.0009987643,0.0002080858,0.00058921217,0.0014921264,0.00077080645],"domain_scores_gemma":[0.9889253,0.0019857911,0.00044728132,0.0006189022,0.0052460246,0.002776682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016111927,0.001707635,0.0014476755,0.0027805998,0.0015932226,0.0039507137,0.0020234345,0.0047318507,0.01645922],"category_scores_gemma":[0.005467294,0.00057662657,0.0017438044,0.0012951351,0.0014062164,0.0026660198,0.002857886,0.004294997,0.006281812],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032267002,0.001961421,0.009704981,0.0018843985,0.00063133624,0.0010298794,0.0005755892,0.0069998084,0.1270146,0.011231331,0.45727706,0.37846282],"study_design_scores_gemma":[0.00015777434,0.0011238828,0.010452025,0.00028701033,0.0003104503,0.00038337306,0.0003654865,0.004990447,0.09744045,0.004845497,0.879517,0.00012653766],"about_ca_topic_score_codex":0.009219147,"about_ca_topic_score_gemma":0.009435029,"teacher_disagreement_score":0.01645922,"about_ca_system_score_codex":0.0021502615,"about_ca_system_score_gemma":0.007078299,"threshold_uncertainty_score":0.08520901},"labels":[],"label_agreement":null},{"id":"W2888360525","doi":"10.1016/j.biologicals.2018.08.004","title":"Report of the international conference on manufacturing and testing of pluripotent stem cells","year":2018,"lang":"en","type":"article","venue":"Biologicals","topic":"Pluripotent Stem Cells Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stemcell Technologies; Health Canada","funders":"National Institutes of Health; Comissão Interministerial para os Recursos do Mar; Novo Nordisk Fonden; World Health Organization","keywords":"Induced pluripotent stem cell; Biology; Genetics; Embryonic stem cell","score_opus":0.06820956123313249,"score_gpt":0.29827132824895236,"score_spread":0.23006176701581987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888360525","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09752797,0.16106062,0.1449048,0.1008553,0.12892257,0.0049892883,0.013969994,0.0013423525,0.34642702],"genre_scores_gemma":[0.1588257,0.08627299,0.07533964,0.018738784,0.019909766,0.0024490433,0.02352382,0.0014094682,0.6135308],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944553,0.00076164416,0.0003629388,0.0004372157,0.0031677887,0.000815043],"domain_scores_gemma":[0.9916699,0.0015016854,0.00046269855,0.00044983052,0.0043759337,0.0015400482],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011886599,0.00200048,0.0010412644,0.00324435,0.0020918516,0.004606825,0.0021412168,0.005020802,0.014143795],"category_scores_gemma":[0.0037671975,0.00053619157,0.001816912,0.0019023238,0.0014641944,0.0021334367,0.0032580986,0.0046155094,0.0056106052],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018959267,0.0021750312,0.0057741823,0.0021101623,0.00022817044,0.0018948774,0.000850584,0.008246109,0.10579018,0.028701538,0.5732358,0.26909745],"study_design_scores_gemma":[0.00006119243,0.0005677742,0.0036824045,0.00024869756,0.00012158802,0.00025470988,0.00028384608,0.0010241604,0.08865212,0.0028721308,0.9021639,0.00006748155],"about_ca_topic_score_codex":0.0068340516,"about_ca_topic_score_gemma":0.0087753795,"teacher_disagreement_score":0.014143795,"about_ca_system_score_codex":0.0029282963,"about_ca_system_score_gemma":0.010673664,"threshold_uncertainty_score":0.06286311},"labels":[],"label_agreement":null},{"id":"W2947532070","doi":"10.1016/j.biologicals.2019.05.002","title":"Octanorm [cutaquig®], a new immunoglobulin (human) subcutaneous 16.5% solution for injection (165 mg/mL) – Biochemical characterization, pathogen safety, and stability","year":2019,"lang":"en","type":"article","venue":"Biologicals","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Antibody; Immune system; Immunoglobulin G; Titer; Chemistry; Subcutaneous injection; Manufacturing process; Immunology; Medicine; Materials science; Internal medicine","score_opus":0.012981846083599938,"score_gpt":0.2285992981866764,"score_spread":0.21561745210307648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947532070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.64714545,0.13514705,0.13098866,0.0014999665,0.001227768,0.0038275255,0.005462607,0.0049741114,0.06972688],"genre_scores_gemma":[0.79915714,0.047707777,0.08602785,0.0020950697,0.0004437096,0.0020460985,0.017626574,0.00063575327,0.044259936],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995771,0.00006203774,0.000030353753,0.000054494485,0.00024783734,0.000028176057],"domain_scores_gemma":[0.9998054,0.000032651664,0.00007184048,0.000014061022,0.00004154312,0.000034449324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004633571,0.00048209872,0.0002884576,0.0008618675,0.00016054627,0.00047036412,0.00036056494,0.00045181232,0.0036547277],"category_scores_gemma":[0.0005203702,0.0001583888,0.00029871988,0.00031311455,0.0002652905,0.0004826707,0.00032208962,0.0006640934,0.0014770383],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014202604,0.0005016471,0.0014658,0.0011808237,0.00007019683,0.00052884343,0.00008816242,0.0003713131,0.7401069,0.0015380771,0.010554858,0.24217312],"study_design_scores_gemma":[0.00064727844,0.006891637,0.010184489,0.0005668233,0.00021023417,0.010374735,0.00007927457,0.0027217872,0.6603715,0.0007692063,0.30707562,0.00010739943],"about_ca_topic_score_codex":0.000593711,"about_ca_topic_score_gemma":0.0006014623,"teacher_disagreement_score":0.0036547277,"about_ca_system_score_codex":0.00024341705,"about_ca_system_score_gemma":0.0005031051,"threshold_uncertainty_score":0.012226224},"labels":[],"label_agreement":null},{"id":"W2953443439","doi":"10.1016/j.biologicals.2019.06.005","title":"Achieving scientific and regulatory success in implementing non-animal approaches to human and veterinary rabies vaccine testing: A NICEATM and IABS workshop report","year":2019,"lang":"en","type":"article","venue":"Biologicals","topic":"Rabies epidemiology and control","field":"Immunology and Microbiology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"National Institute of Environmental Health Sciences; National Institutes of Health; Erzincan Üniversitesi; European Commission; Boehringer Ingelheim; U.S. Department of Agriculture","keywords":"Potency; Rabies vaccine; Rabies; Test (biology); Medicine; Government (linguistics); Veterinary medicine; Biotechnology; Rabies virus; Virology; Biology; In vitro","score_opus":0.13282198521807548,"score_gpt":0.3131334991516462,"score_spread":0.1803115139335707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953443439","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06611762,0.044622686,0.04847555,0.67060953,0.0457255,0.006178132,0.001220857,0.0012288275,0.11582127],"genre_scores_gemma":[0.45041552,0.035822704,0.13621578,0.179402,0.012594178,0.007747458,0.0043316176,0.0013530466,0.17211771],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.92000616,0.034809135,0.0038680413,0.0038562699,0.026018107,0.011442204],"domain_scores_gemma":[0.9406524,0.0114496965,0.0039487933,0.0025378324,0.029646084,0.011765191],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.14115404,0.0020068313,0.0010660188,0.0014102523,0.0040461267,0.015262984,0.006058036,0.013775049,0.006585659],"category_scores_gemma":[0.04280837,0.0015458703,0.0033415821,0.00073365186,0.0035406104,0.0062283925,0.016928136,0.014613514,0.0029041131],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012357703,0.002083235,0.0065973094,0.0076372316,0.0004142875,0.0038236685,0.015672226,0.0039854655,0.049891494,0.03038435,0.596905,0.28136992],"study_design_scores_gemma":[0.00013362359,0.0019103776,0.007169846,0.0023016778,0.000078288285,0.000712945,0.008598746,0.00080247666,0.0102012465,0.0035923012,0.96421045,0.00028806654],"about_ca_topic_score_codex":0.0058097052,"about_ca_topic_score_gemma":0.010175857,"teacher_disagreement_score":0.14115404,"about_ca_system_score_codex":0.010279949,"about_ca_system_score_gemma":0.025674835,"threshold_uncertainty_score":0.7465028},"labels":[],"label_agreement":null},{"id":"W2981766175","doi":"10.1016/j.biologicals.2019.10.008","title":"Quality changes to approved biotherapeutic product: Simulated case studies on reporting categories &amp; supporting data requirements","year":2019,"lang":"en","type":"review","venue":"Biologicals","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"World Health Organization","keywords":"Quality (philosophy); Product (mathematics); Business; Process management; Process (computing); Order (exchange); Operations management; Risk analysis (engineering); Computer science; Engineering; Finance","score_opus":0.7420894449380853,"score_gpt":0.5846845918852744,"score_spread":0.15740485305281082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981766175","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26046,0.4180368,0.09205175,0.03269299,0.0022916014,0.044947993,0.006283233,0.00044329904,0.14279234],"genre_scores_gemma":[0.6215953,0.23296644,0.109511845,0.004628111,0.00039999597,0.01421012,0.002138399,0.000092829374,0.014456871],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9708964,0.018864704,0.0034114865,0.0007985567,0.0054130843,0.000615903],"domain_scores_gemma":[0.9612843,0.027830413,0.003552958,0.0016453555,0.00532427,0.0003627279],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.034760997,0.00063354796,0.0008117681,0.0016756002,0.00079837046,0.0016457018,0.0020756775,0.0026423517,0.0046688593],"category_scores_gemma":[0.039357744,0.00044933107,0.0011831034,0.0024391215,0.0009295851,0.0019277472,0.0016293057,0.0011280575,0.00088289485],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010689453,0.0014780756,0.009712009,0.063265584,0.0003449214,0.008259842,0.011944984,0.01211079,0.005265709,0.05056727,0.04951002,0.78647184],"study_design_scores_gemma":[0.00039689385,0.0017282245,0.0074989684,0.022524362,0.0005354167,0.007681495,0.008020822,0.0034415175,0.011096109,0.007892341,0.92905307,0.00013070596],"about_ca_topic_score_codex":0.0037390045,"about_ca_topic_score_gemma":0.0068797627,"teacher_disagreement_score":0.965239,"about_ca_system_score_codex":0.0032695448,"about_ca_system_score_gemma":0.0059367367,"threshold_uncertainty_score":0.18383592},"labels":[],"label_agreement":null},{"id":"W2999642303","doi":"10.1016/j.biologicals.2019.12.008","title":"WHO implementation workshop on guidelines on procedures and data requirements for changes to approved biotherapeutic products, Seoul, Republic of Korea, 25–26 June 2019","year":2020,"lang":"en","type":"article","venue":"Biologicals","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"Ministry of Food and Drug Safety; World Health Organization","keywords":"Guideline; CLARITY; Product (mathematics); Business; Medicine; Medical education","score_opus":0.3059629528580957,"score_gpt":0.45261058716641406,"score_spread":0.14664763430831834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999642303","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0121640805,0.03260572,0.054927822,0.6542784,0.039121557,0.021156125,0.025720326,0.0033543243,0.15667172],"genre_scores_gemma":[0.047833577,0.034064993,0.22564211,0.4383332,0.0067885737,0.02317186,0.038905174,0.0023733065,0.18288723],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9540283,0.0182677,0.009636422,0.0014629603,0.011347574,0.0052571],"domain_scores_gemma":[0.909493,0.028685423,0.010672762,0.005365399,0.03900864,0.0067747524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.1355507,0.0020609812,0.001555385,0.005032292,0.0029542812,0.006932664,0.008793739,0.020032618,0.014898076],"category_scores_gemma":[0.084740736,0.0027062756,0.0047862506,0.0029880207,0.003563499,0.004044584,0.006439158,0.01666104,0.007808112],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040987003,0.0008511041,0.0031848084,0.0022615506,0.00012240562,0.00097041635,0.0020276036,0.0010124694,0.0045181974,0.009484377,0.88404673,0.09111051],"study_design_scores_gemma":[0.00020993275,0.0002160826,0.007807647,0.0065772757,0.00012985403,0.00037089217,0.0014002204,0.00028783505,0.0029431854,0.0026549934,0.9773047,0.00009737339],"about_ca_topic_score_codex":0.051805634,"about_ca_topic_score_gemma":0.0473488,"teacher_disagreement_score":0.1355507,"about_ca_system_score_codex":0.0066906833,"about_ca_system_score_gemma":0.07146222,"threshold_uncertainty_score":0.7168691},"labels":[],"label_agreement":null},{"id":"W3008781252","doi":"10.1016/j.biologicals.2020.02.003","title":"Report of the 2019 NIST-FDA workshop on standards for next generation sequencing detection of viral adventitious agents in biologics and biomanufacturing","year":2020,"lang":"en","type":"article","venue":"Biologicals","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada)","funders":"","keywords":"Food and drug administration; Biomanufacturing; Standardization; Biotechnology; Medicine; Computer science; Biology; Risk analysis (engineering)","score_opus":0.11266259333185935,"score_gpt":0.3514924686337048,"score_spread":0.23882987530184546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008781252","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.053199634,0.03394968,0.180812,0.44488344,0.053496897,0.0085788565,0.015033038,0.0039017678,0.20614475],"genre_scores_gemma":[0.16815346,0.01909025,0.16397537,0.2368447,0.0064100297,0.0037252076,0.024690606,0.001106991,0.37600332],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9768033,0.0031325365,0.00088842935,0.0011811719,0.015624871,0.0023696013],"domain_scores_gemma":[0.9798995,0.0038714248,0.0015456,0.00086268777,0.011243808,0.0025769765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.037343014,0.0019081542,0.0012178029,0.0029189915,0.0044754087,0.0056160376,0.004455155,0.02133388,0.007237076],"category_scores_gemma":[0.01643042,0.0013825794,0.0023816004,0.0011378927,0.0028854213,0.0028525016,0.004133116,0.011862105,0.0041081225],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012482054,0.002356268,0.0056338687,0.0012339704,0.00024839974,0.0020077298,0.0008245414,0.0042627254,0.14212611,0.022800514,0.7123475,0.10491017],"study_design_scores_gemma":[0.00015812943,0.0009950289,0.004999604,0.0004328672,0.00019358983,0.000519516,0.00042267537,0.002706036,0.087608464,0.0055089816,0.89627934,0.00017576599],"about_ca_topic_score_codex":0.034651253,"about_ca_topic_score_gemma":0.069256656,"teacher_disagreement_score":0.037343014,"about_ca_system_score_codex":0.007637294,"about_ca_system_score_gemma":0.03922305,"threshold_uncertainty_score":0.19749105},"labels":[],"label_agreement":null},{"id":"W3013519416","doi":"10.1016/j.biologicals.2020.02.005","title":"The regulatory landscape of biosimilars: WHO efforts and progress made from 2009 to 2019","year":2020,"lang":"en","type":"review","venue":"Biologicals","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"Ministry of Health and Welfare; World Health Organization","keywords":"Biosimilar; Business; Terminology; Competition (biology); Quality (philosophy); Risk analysis (engineering); Medicine","score_opus":0.04131380638215703,"score_gpt":0.33282749076361606,"score_spread":0.291513684381459,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013519416","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019112726,0.9930998,0.0001772936,0.0035514983,0.00037690808,0.000008738413,0.000040742034,0.000011496839,0.0025424063],"genre_scores_gemma":[0.0022234006,0.99399865,0.00034404075,0.0022721412,0.00031808068,0.0000137571415,0.000071623705,0.000005426879,0.00075295265],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998192,0.00044715294,0.00026363766,0.00019122532,0.00072547595,0.00018042627],"domain_scores_gemma":[0.9971064,0.00124634,0.00048755456,0.000058240727,0.0009582399,0.0001432109],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00480894,0.00064313586,0.0008358167,0.0022309707,0.00036611388,0.0018380677,0.0010184975,0.0018891484,0.0024876548],"category_scores_gemma":[0.0055409265,0.00027709495,0.00080043357,0.0030688331,0.0009888334,0.0023808198,0.0010741159,0.0024651426,0.0009516857],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001063714,0.00004201952,0.00024172681,0.017040467,0.00005023096,0.00018113118,0.00023005452,0.0004166027,0.0010228385,0.019112397,0.046903837,0.91465235],"study_design_scores_gemma":[0.000010697403,0.000050669914,0.0005841426,0.006470424,0.000060294995,0.00032492343,0.0000885609,0.00006117848,0.0004467889,0.0018111794,0.9900803,0.000010886773],"about_ca_topic_score_codex":0.0044752704,"about_ca_topic_score_gemma":0.0036756804,"teacher_disagreement_score":0.00480894,"about_ca_system_score_codex":0.0026952776,"about_ca_system_score_gemma":0.00790058,"threshold_uncertainty_score":0.025432467},"labels":[],"label_agreement":null},{"id":"W3033731386","doi":"10.1016/j.biologicals.2020.04.004","title":"Third human challenge trial conference, Oxford, United Kingdom, February 6–7, 2020, a meeting report","year":2020,"lang":"en","type":"article","venue":"Biologicals","topic":"Viral Infections and Outbreaks Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Medical Research Council; Wellcome Trust","keywords":"Delegation; Standardization; Political science; Medicine; Public relations; Law","score_opus":0.22413496586953424,"score_gpt":0.3994632462707512,"score_spread":0.17532828040121695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033731386","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01561562,0.05186696,0.0035551456,0.49617845,0.19983399,0.0060474086,0.05552854,0.00069363014,0.17068036],"genre_scores_gemma":[0.061280742,0.017847124,0.0076565556,0.27733085,0.063775495,0.008317076,0.03583031,0.0005275748,0.5274343],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99614453,0.001867973,0.00018520872,0.0003043684,0.0009475612,0.00055036275],"domain_scores_gemma":[0.988493,0.0035877519,0.0007789381,0.0003806221,0.0019660029,0.0047937254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013781093,0.0012363737,0.0016139846,0.00040653412,0.0012860193,0.004909865,0.0013124051,0.01012838,0.06385544],"category_scores_gemma":[0.021525487,0.0007155553,0.0014745165,0.00037498522,0.00096872,0.0015551627,0.0012968268,0.008051664,0.01797832],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007514647,0.000104316954,0.00025604706,0.00025211275,0.00006263887,0.000052501302,0.000019907797,0.000070862065,0.0002088962,0.0004829585,0.98153865,0.009436474],"study_design_scores_gemma":[0.012619236,0.0011323584,0.004445062,0.0007857251,0.00016924556,0.000077617464,0.000083966275,0.0002981992,0.00043955137,0.00124195,0.978663,0.000044083277],"about_ca_topic_score_codex":0.012551874,"about_ca_topic_score_gemma":0.04504187,"teacher_disagreement_score":0.06385544,"about_ca_system_score_codex":0.0043455954,"about_ca_system_score_gemma":0.008510768,"threshold_uncertainty_score":0.21361774},"labels":[],"label_agreement":null},{"id":"W3080928896","doi":"10.1016/j.biologicals.2020.08.010","title":"SARS-CoV-2 and the safety margins of cell-based biological medicinal products","year":2020,"lang":"en","type":"article","venue":"Biologicals","topic":"Biomedical and Engineering Education","field":"Engineering","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Takeda Canada","keywords":"Biomanufacturing; Virology; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Pandemic; Coronavirus disease 2019 (COVID-19); Industrial fermentation; 2019-20 coronavirus outbreak; Virus; Biology; Cell culture; Biotechnology; Medicine; Food science; Fermentation; Infectious disease (medical specialty); Outbreak; Disease","score_opus":0.03785850765158746,"score_gpt":0.22793506687077408,"score_spread":0.19007655921918662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3080928896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9789807,0.0070191678,0.004567497,0.00048825383,0.00008959708,0.000036475158,0.00023982543,0.000044262666,0.0085340785],"genre_scores_gemma":[0.9968251,0.00069714047,0.0008686849,0.00009292422,0.000023119375,0.00000942997,0.00013976183,0.000005698512,0.0013381388],"study_design_codex":"bench_or_experimental","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9993204,0.00015119303,0.00003186565,0.000067454304,0.00035002863,0.00007916839],"domain_scores_gemma":[0.9992405,0.00016748527,0.0002644361,0.000053142485,0.00022428492,0.000050120434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008640223,0.00028643513,0.00014073245,0.00027310543,0.00024086691,0.0007753678,0.00021050338,0.000548565,0.00298031],"category_scores_gemma":[0.0011510354,0.00012261177,0.0002105682,0.00013651505,0.00036603864,0.00040599427,0.00044820493,0.00033339986,0.00056207925],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056932314,0.00007828712,0.0036838066,0.00010143055,0.000015555814,0.0001821887,0.00013401314,0.0014331747,0.98049587,0.001121599,0.00022661817,0.0119580645],"study_design_scores_gemma":[0.000016594307,0.0017129799,0.011831809,0.00004362376,0.000026048145,0.00041248556,0.00034574314,0.0022389833,0.97413063,0.001106511,0.008119407,0.000015248925],"about_ca_topic_score_codex":0.00059748656,"about_ca_topic_score_gemma":0.0003238666,"teacher_disagreement_score":0.00298031,"about_ca_system_score_codex":0.00028877656,"about_ca_system_score_gemma":0.0003685171,"threshold_uncertainty_score":0.009970188},"labels":[],"label_agreement":null},{"id":"W3091934739","doi":"10.1016/j.biologicals.2020.07.010","title":"Animal testing for vaccines. Implementing replacement, reduction and refinement: challenges and priorities","year":2020,"lang":"en","type":"article","venue":"Biologicals","topic":"Viral Infectious Diseases and Gene Expression in Insects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"Innovative Medicines Initiative; Humane Society International; European Federation of Pharmaceutical Industries and Associations; Bill and Melinda Gates Foundation","keywords":"Harmonization; Standardization; Alliance; Consistency (knowledge bases); Work (physics); Business; Medicine; Political science; Computer science; Engineering","score_opus":0.07222429780345258,"score_gpt":0.30801357871267665,"score_spread":0.23578928090922407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091934739","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003254542,0.17882296,0.016670452,0.7658411,0.006876618,0.0005532966,0.00021420345,0.00020435927,0.027562482],"genre_scores_gemma":[0.11336203,0.41010737,0.19690998,0.23192507,0.007881053,0.0011434641,0.0010600971,0.00029006993,0.037320875],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97080845,0.015950829,0.0019766495,0.0014210521,0.007878587,0.0019644212],"domain_scores_gemma":[0.9555419,0.018164549,0.0041047554,0.0022286477,0.012963796,0.0069963285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.07044582,0.0015154443,0.0012019399,0.0016895732,0.0025351571,0.011517249,0.0025020335,0.006885786,0.007829486],"category_scores_gemma":[0.023816962,0.00080234004,0.0007181129,0.0019839269,0.0086939875,0.012793216,0.005321503,0.010208669,0.0030300855],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021731238,0.0005203206,0.004385435,0.008902383,0.000057212947,0.0004943887,0.0041535115,0.0013232414,0.008980214,0.10664248,0.2053383,0.65898514],"study_design_scores_gemma":[0.000030766387,0.0005684441,0.0045112935,0.006099698,0.000033022756,0.00078384846,0.01397517,0.00068451336,0.0029339106,0.060570426,0.9097257,0.00008318214],"about_ca_topic_score_codex":0.009069974,"about_ca_topic_score_gemma":0.013507613,"teacher_disagreement_score":0.07044582,"about_ca_system_score_codex":0.008021216,"about_ca_system_score_gemma":0.035483558,"threshold_uncertainty_score":0.37255758},"labels":[],"label_agreement":null},{"id":"W3093091675","doi":"10.1016/j.biologicals.2020.09.003","title":"Replacing the in vivo toxin challenge test with an in vitro assay for assessment of potency for diphtheria toxoid containing vaccines","year":2020,"lang":"en","type":"article","venue":"Biologicals","topic":"Diphtheria, Corynebacterium, and Tetanus","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada)","funders":"","keywords":"Diphtheria toxin; Potency; Diphtheria; Toxoid; In vivo; Immunization; In vitro toxicology; Medicine; Virology; In vitro; Antibody; Toxin; Vaccination; Microbiology; Chemistry; Biology; Immunology; Biotechnology; Biochemistry","score_opus":0.03901331657394204,"score_gpt":0.30048690906763964,"score_spread":0.2614735924936976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093091675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6803087,0.0031803364,0.2859269,0.00078107294,0.001955101,0.0034994646,0.003658632,0.0024823395,0.018207438],"genre_scores_gemma":[0.84102196,0.0027419552,0.120291814,0.00083886186,0.00029313617,0.002625778,0.005512992,0.00063065713,0.02604278],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99538815,0.0020555495,0.000349547,0.0005382076,0.0012417071,0.00042686696],"domain_scores_gemma":[0.99391645,0.0026776828,0.00052403065,0.0012727237,0.0011830709,0.00042605682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020537972,0.0025649362,0.0017338968,0.0011745017,0.0006556885,0.0013928462,0.0011613938,0.0019584284,0.0028319964],"category_scores_gemma":[0.003548359,0.000871739,0.0011367974,0.0009968042,0.0013554004,0.0012215746,0.0012334154,0.0051461617,0.0025032952],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023711004,0.00041493063,0.00050146534,0.00010799114,0.000014921642,0.000024070976,0.000082913466,0.00019629745,0.99584085,0.00022427067,0.0001300601,0.0022250859],"study_design_scores_gemma":[0.000017390532,0.0026420867,0.0011427962,0.000013279925,0.00002756773,0.00010049076,0.000033085314,0.00070337846,0.9943328,0.00007939185,0.0008928194,0.000014896402],"about_ca_topic_score_codex":0.0028377008,"about_ca_topic_score_gemma":0.0034454474,"teacher_disagreement_score":0.0028377008,"about_ca_system_score_codex":0.00085639214,"about_ca_system_score_gemma":0.0014425342,"threshold_uncertainty_score":0.010861635},"labels":[],"label_agreement":null},{"id":"W3160701503","doi":"10.1016/j.biologicals.2021.04.005","title":"IABS/CEPI platform technology webinar: Is it possible to reduce the vaccine development time?","year":2021,"lang":"en","type":"article","venue":"Biologicals","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"Coalition for Epidemic Preparedness Innovations; World Health Organization; Bill and Melinda Gates Foundation","keywords":"Preparedness; Standardization; Coronavirus disease 2019 (COVID-19); Alliance; Pandemic; Joint venture; Emerging technologies; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Business; Technology development; Process (computing); Computer science; Risk analysis (engineering); Process management; Infectious disease (medical specialty); Engineering; Medicine; Disease; Political science; Management; Manufacturing engineering; Economics","score_opus":0.0818162448890902,"score_gpt":0.37796313876282894,"score_spread":0.2961468938737387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3160701503","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.031026788,0.03803599,0.06281698,0.55985594,0.020965144,0.0016654325,0.003955323,0.014430883,0.26724753],"genre_scores_gemma":[0.27305803,0.05527163,0.22267543,0.104487985,0.007941269,0.0025669702,0.015392182,0.0061935885,0.31241295],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957072,0.0017170083,0.00025871393,0.00028526245,0.0014545673,0.0005772245],"domain_scores_gemma":[0.98497635,0.0041446527,0.0011898231,0.00066294207,0.00491204,0.0041142483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016456956,0.0006827898,0.0004661826,0.0013621885,0.0011817659,0.005651732,0.0015290581,0.00360743,0.051975336],"category_scores_gemma":[0.02102933,0.00041448243,0.00043362076,0.001053034,0.0007662044,0.007168413,0.0018200055,0.0034820128,0.029606417],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050603127,0.00041091605,0.001913086,0.00079385703,0.000016759914,0.00016929045,0.0004911038,0.00025893224,0.0047987015,0.0068708407,0.63462985,0.3491408],"study_design_scores_gemma":[0.00009827645,0.00030965862,0.0032099723,0.00045722825,0.000017924493,0.00023908807,0.00085835054,0.0009310193,0.0034323365,0.0031421587,0.98725677,0.00004719904],"about_ca_topic_score_codex":0.0034706427,"about_ca_topic_score_gemma":0.005340902,"teacher_disagreement_score":0.051975336,"about_ca_system_score_codex":0.0017615829,"about_ca_system_score_gemma":0.0053120973,"threshold_uncertainty_score":0.17387486},"labels":[],"label_agreement":null},{"id":"W3204361907","doi":"10.1016/j.biologicals.2021.09.002","title":"Controlled Human Infection Studies: Proposals for guidance on how to design, develop and produce a challenge strain","year":2021,"lang":"en","type":"article","venue":"Biologicals","topic":"Viral gastroenteritis research and epidemiology","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"Medical Research Council; Wellcome Trust","keywords":"Documentation; Quality (philosophy); Good manufacturing practice; Process (computing); Product (mathematics); Risk analysis (engineering); Control (management); Process management; Computer science; Quality by Design; New product development; Manufacturing process; Manufacturing engineering; Business; Operations management; Engineering; Marketing","score_opus":0.2536574262357846,"score_gpt":0.4428838146075007,"score_spread":0.18922638837171613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3204361907","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006130971,0.037106976,0.62664956,0.097474866,0.010077405,0.09407891,0.011418361,0.005261345,0.11180164],"genre_scores_gemma":[0.00923715,0.02523746,0.8391462,0.022928128,0.0017137846,0.05481593,0.0054050735,0.00084128673,0.040675066],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.89100736,0.07456548,0.00892481,0.0030602904,0.019735085,0.0027069547],"domain_scores_gemma":[0.8878903,0.051951636,0.010675944,0.02317994,0.021556582,0.00474569],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.16666815,0.00356573,0.003346975,0.0049873735,0.0025124575,0.007093828,0.008731049,0.01931411,0.022154588],"category_scores_gemma":[0.10507742,0.0030158195,0.0042749923,0.0036416848,0.007694748,0.0068434565,0.005004523,0.0094612865,0.022376133],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002057765,0.0031721834,0.002782571,0.012971092,0.00020734867,0.0014047821,0.0025372482,0.0030416157,0.028640987,0.091478065,0.41018483,0.4415214],"study_design_scores_gemma":[0.00091535866,0.0038061114,0.003024157,0.006771669,0.0001888254,0.00078991364,0.0007737874,0.0010255481,0.011883493,0.025494507,0.94504744,0.0002790901],"about_ca_topic_score_codex":0.006207893,"about_ca_topic_score_gemma":0.010980287,"teacher_disagreement_score":0.16666815,"about_ca_system_score_codex":0.0034721901,"about_ca_system_score_gemma":0.031240623,"threshold_uncertainty_score":0.88143593},"labels":[],"label_agreement":null},{"id":"W4224288018","doi":"10.1016/j.biologicals.2022.03.001","title":"WHO informal consultation on revision of guidelines on evaluation of similar biotherapeutic products, virtual meeting, 30 June – 2 July 2021","year":2022,"lang":"en","type":"article","venue":"Biologicals","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"Ministry of Health and Welfare; World Health Organization","keywords":"CLARITY; Biosimilar; Flexibility (engineering); Standardization; Medicine; Engineering ethics; Risk analysis (engineering); Management science; Business; Medical education; Engineering management; Political science; Engineering; Law; Management","score_opus":0.1113743065632104,"score_gpt":0.378385527609463,"score_spread":0.2670112210462526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224288018","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005555775,0.023738978,0.014471138,0.74450636,0.10405789,0.0044235648,0.0036802487,0.00073636137,0.09882963],"genre_scores_gemma":[0.053445593,0.021996144,0.035782285,0.5443159,0.041198052,0.0060949726,0.004494845,0.0012809513,0.29139134],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9808903,0.009440454,0.0028459039,0.0008244368,0.0039234185,0.0020755157],"domain_scores_gemma":[0.97066903,0.010351289,0.0022334475,0.00093020656,0.013051841,0.0027641975],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.033377714,0.0012285847,0.0009306835,0.0020045368,0.0034919544,0.0045487904,0.0022859462,0.014885547,0.023848502],"category_scores_gemma":[0.06197774,0.00090337923,0.0019380602,0.0011494467,0.002416536,0.0031835441,0.005559966,0.010277261,0.013413726],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011225417,0.000051031995,0.00029718125,0.00038061608,0.000011307337,0.0010904849,0.0015033487,0.00011414955,0.0010748904,0.0018016543,0.974021,0.019542158],"study_design_scores_gemma":[0.00004466093,0.000041032446,0.00083592033,0.0006769783,0.000013154955,0.0004217854,0.0011046346,0.000113842034,0.00043179802,0.0010524221,0.9952272,0.000036499332],"about_ca_topic_score_codex":0.018671244,"about_ca_topic_score_gemma":0.030475844,"teacher_disagreement_score":0.9666223,"about_ca_system_score_codex":0.007813002,"about_ca_system_score_gemma":0.021466939,"threshold_uncertainty_score":0.17652035},"labels":[],"label_agreement":null},{"id":"W4285097669","doi":"10.1016/j.biologicals.2022.06.003","title":"Accelerating Global Deletion of the Abnormal Toxicity Test for vaccines and biologicals. Planning common next steps. A workshop Report","year":2022,"lang":"en","type":"article","venue":"Biologicals","topic":"Animal testing and alternatives","field":"Veterinary","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"World Health Organization; Bill and Melinda Gates Foundation","keywords":"Standardization; Test (biology); Alliance; Business; Medicine; Political science; Biology","score_opus":0.31995780295158077,"score_gpt":0.4275266073901094,"score_spread":0.10756880443852862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285097669","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.045080364,0.029442122,0.24048418,0.43696767,0.028349273,0.014725622,0.003605669,0.003773829,0.19757137],"genre_scores_gemma":[0.22608216,0.022037249,0.3506552,0.1826869,0.0065079983,0.008815484,0.01098653,0.0016768809,0.19055155],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97531736,0.010008467,0.0015908265,0.001690288,0.007088225,0.004304793],"domain_scores_gemma":[0.9548885,0.011356197,0.00448287,0.0033107677,0.015962726,0.009998902],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.073058166,0.0020169886,0.0007887438,0.0017118908,0.002765741,0.006438844,0.004908959,0.008655316,0.022904027],"category_scores_gemma":[0.029827032,0.0010970968,0.0028924497,0.0006148126,0.0027092528,0.007795378,0.014071028,0.009903452,0.007985297],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010973715,0.0017212753,0.004999082,0.002992526,0.00015328001,0.003072165,0.0041142036,0.005002215,0.029083528,0.03045451,0.42997706,0.48733276],"study_design_scores_gemma":[0.00016025594,0.0017209202,0.0039038933,0.0013513824,0.00011125722,0.0012069449,0.0038252864,0.000959774,0.014012095,0.020199498,0.95240545,0.00014335524],"about_ca_topic_score_codex":0.0045940466,"about_ca_topic_score_gemma":0.0061612027,"teacher_disagreement_score":0.9269418,"about_ca_system_score_codex":0.003472088,"about_ca_system_score_gemma":0.02865492,"threshold_uncertainty_score":0.3863731},"labels":[],"label_agreement":null},{"id":"W4308327388","doi":"10.1016/j.biologicals.2022.11.001","title":"Corrigendum to “Replacing the in vivo toxin challenge test with an in vitro assay for assessment of potency for diphtheria toxoid containing vaccines” [Biologicals 68 (2020) 19–25]","year":2022,"lang":"en","type":"erratum","venue":"Biologicals","topic":"Toxin Mechanisms and Immunotoxins","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada)","funders":"","keywords":"Potency; Diphtheria toxin; Toxoid; Diphtheria; In vivo; In vitro; In vitro toxicology; Toxin; Microbiology; Pharmacology; Chemistry; Medicine; Virology; Biology; Biotechnology; Vaccination; Tetanus; Biochemistry","score_opus":0.03930016330654674,"score_gpt":0.2994283051198831,"score_spread":0.2601281418133364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308327388","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000105557236,0.0026324575,0.0006077627,0.043623716,0.92724437,0.00010381384,0.0011290244,0.0003649511,0.024188427],"genre_scores_gemma":[0.0021407523,0.006590533,0.0025807826,0.11750399,0.115328796,0.00024092355,0.0022237047,0.00056885753,0.7528216],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957777,0.00044705262,0.00045545385,0.0005492762,0.0023558803,0.00041463083],"domain_scores_gemma":[0.98878443,0.0022032838,0.00048557328,0.00066017883,0.0072532115,0.0006133927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031742486,0.0033195142,0.0029643252,0.0050772373,0.00489642,0.004092994,0.004508735,0.012466014,0.059496403],"category_scores_gemma":[0.016949266,0.0020143508,0.0025906898,0.0022326377,0.002164017,0.0024070549,0.0023216147,0.011657789,0.061524004],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013624111,0.000014358276,0.000017836372,0.000045870827,0.0000042014008,0.0000610287,0.0000051928337,0.000024542398,0.00008233176,0.00027555166,0.99588686,0.0035685918],"study_design_scores_gemma":[0.000021894495,0.00002345082,0.0008106629,0.00011793901,0.000023315106,0.00008971351,0.00001946945,0.00013209929,0.00028992648,0.0006380047,0.99780756,0.000025915595],"about_ca_topic_score_codex":0.08728675,"about_ca_topic_score_gemma":0.15424585,"teacher_disagreement_score":0.08728675,"about_ca_system_score_codex":0.0073497044,"about_ca_system_score_gemma":0.0070121377,"threshold_uncertainty_score":0.19903529},"labels":[],"label_agreement":null},{"id":"W4368348217","doi":"10.1016/j.biologicals.2023.101683","title":"Development of a droplet digital PCR for pertussis toxin locus copy number determination in a genetically-modified Bordetella pertussis strain","year":2023,"lang":"en","type":"article","venue":"Biologicals","topic":"Bacterial Infections and Vaccines","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada)","funders":"Sanofi Pasteur","keywords":"Locus (genetics); Bordetella pertussis; Pertussis toxin; Biology; Gene; Strain (injury); Digital polymerase chain reaction; Genetics; Polymerase chain reaction; Bacteria; Receptor; G protein","score_opus":0.04153103462502097,"score_gpt":0.30193191874022673,"score_spread":0.2604008841152058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4368348217","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3133423,0.0006702899,0.6780492,0.00034874145,0.00025615576,0.0014767754,0.002030949,0.0021242937,0.0017013095],"genre_scores_gemma":[0.24659823,0.00066280283,0.7436103,0.00023232201,0.000042678246,0.001451697,0.002225948,0.00041024695,0.004765727],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99749196,0.00042592047,0.00021313559,0.000899457,0.00082749524,0.0001420855],"domain_scores_gemma":[0.9979036,0.0010240461,0.00039188127,0.00028422958,0.00028779675,0.000108550135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016988427,0.0010157349,0.00093094434,0.0010000127,0.00024305665,0.0008860957,0.0010963817,0.0011130663,0.0017813703],"category_scores_gemma":[0.0033487265,0.0009778995,0.00070506346,0.00051414734,0.0007216164,0.00062643114,0.0006718417,0.0017259382,0.001406939],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018810853,0.0000262772,0.00011120245,0.000026243015,0.000002683026,0.000011123199,0.000017478484,0.00007304946,0.9981919,0.00004667988,0.00001764373,0.0014567974],"study_design_scores_gemma":[0.000009921656,0.00021052989,0.0006486979,0.0000069797447,0.000014124989,0.000106979795,0.000015052415,0.002544725,0.99568105,0.000054240525,0.0006944158,0.000013188081],"about_ca_topic_score_codex":0.0005283071,"about_ca_topic_score_gemma":0.00079617975,"teacher_disagreement_score":0.0017813703,"about_ca_system_score_codex":0.00057611405,"about_ca_system_score_gemma":0.00045240988,"threshold_uncertainty_score":0.008984387},"labels":[],"label_agreement":null},{"id":"W4385064422","doi":"10.1016/j.biologicals.2023.101696","title":"Report of the third conference on next-generation sequencing for adventitious virus detection in biologics for humans and animals","year":2023,"lang":"en","type":"article","venue":"Biologicals","topic":"Animal Virus Infections Studies","field":"Agricultural and Biological Sciences","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"World Health Organization","keywords":"Standardization; Food and drug administration; Workflow; Government (linguistics); DNA sequencing; Biotechnology; Alliance; Medicine; Business; Biology; Risk analysis (engineering); Political science; Computer science; Gene","score_opus":0.26073826987097715,"score_gpt":0.3172537208268608,"score_spread":0.05651545095588367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385064422","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030917976,0.05830435,0.12405376,0.26840243,0.31824854,0.013775982,0.009185089,0.0017922737,0.17531969],"genre_scores_gemma":[0.07348529,0.038608465,0.109879196,0.11285576,0.04691367,0.007991804,0.019793008,0.0016829993,0.5887897],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9866952,0.0022324917,0.0005735856,0.0011208445,0.007728769,0.0016491445],"domain_scores_gemma":[0.98084325,0.0032062503,0.0009786492,0.0008491736,0.010609995,0.003512757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02764913,0.002025049,0.0011026427,0.0022902817,0.003682599,0.0071872827,0.003572009,0.011367421,0.014976855],"category_scores_gemma":[0.011881795,0.0007813426,0.002553956,0.0010455651,0.0018383038,0.0027690176,0.0038697529,0.009796079,0.0067851683],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063570874,0.0007768113,0.0020055254,0.00082952774,0.000131148,0.001089879,0.00045383006,0.0019748905,0.028837694,0.0061003594,0.85161924,0.10554546],"study_design_scores_gemma":[0.000057297137,0.0002707719,0.0021023722,0.00024689967,0.00006754067,0.00018436096,0.00023261333,0.000765308,0.014357684,0.0018762121,0.97976065,0.000078213496],"about_ca_topic_score_codex":0.017062798,"about_ca_topic_score_gemma":0.027842049,"teacher_disagreement_score":0.02764913,"about_ca_system_score_codex":0.004980925,"about_ca_system_score_gemma":0.024784977,"threshold_uncertainty_score":0.14622432},"labels":[],"label_agreement":null},{"id":"W4385664125","doi":"10.1016/j.biologicals.2023.101698","title":"Stability of lyophilized Meningococcal A conjugate vaccine, (MenAfriVac™) at elevated temperatures to support controlled temperature chain (CTC) claim","year":2023,"lang":"en","type":"article","venue":"Biologicals","topic":"Bacterial Infections and Vaccines","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Health Canada","keywords":"Vial; Conjugate; Meningococcal vaccine; Conjugate vaccine; Potency; Cold chain; Neisseria meningitidis; Consistency (knowledge bases); Product (mathematics); Medicine; Chemistry; Chromatography; Immunization; Mathematics; Antigen; Food science; Immunology; Biology","score_opus":0.026817384635690375,"score_gpt":0.2790891226149432,"score_spread":0.2522717379792528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385664125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99665785,0.0005773088,0.0012558703,0.000042536667,0.000039367274,0.000011469353,0.0003411777,0.000028492968,0.0010459905],"genre_scores_gemma":[0.99798584,0.00017823283,0.00047724447,0.000018552477,0.0000070183883,0.0000073005376,0.00035289078,0.000011349385,0.00096152705],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983037,0.000025567826,0.000015304406,0.00004053232,0.000049705537,0.00003859673],"domain_scores_gemma":[0.9997937,0.00004629561,0.000048901682,0.000022902868,0.00006980841,0.000018366714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034686667,0.0001922834,0.0001122233,0.00014014643,0.00021317048,0.00024309561,0.00021767638,0.00020102698,0.0023228773],"category_scores_gemma":[0.00079242355,0.00008586405,0.00016057644,0.00020211402,0.00019019921,0.00027424228,0.00012488382,0.0004125595,0.0004140524],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082147,0.00008252059,0.0015861809,0.000056340956,0.000025075888,0.00008734934,0.00015817782,0.0007648633,0.9914077,0.00027954052,0.00021053167,0.004520172],"study_design_scores_gemma":[0.000015125817,0.00065218087,0.0051847347,0.0000139704425,0.000020878346,0.00008215718,0.00006497383,0.0015177547,0.9907479,0.00006506857,0.0016231558,0.000012066785],"about_ca_topic_score_codex":0.0015818976,"about_ca_topic_score_gemma":0.0009786008,"teacher_disagreement_score":0.0023228773,"about_ca_system_score_codex":0.00027734894,"about_ca_system_score_gemma":0.0003070201,"threshold_uncertainty_score":0.0077708364},"labels":[],"label_agreement":null},{"id":"W4387387969","doi":"10.1016/j.biologicals.2023.101714","title":"Emergence of SARS-CoV-2 variant of interest B.1.525 (Eta) in Bangladesh","year":2023,"lang":"en","type":"article","venue":"Biologicals","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sciencetech (Canada)","funders":"","keywords":"Mutation; Biology; Virology; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Gene; Genetics; Coronavirus; Genome; Spike Protein; Lineage (genetic); Strain (injury); Coronavirus disease 2019 (COVID-19); Medicine","score_opus":0.24020871811208122,"score_gpt":0.4197195344675895,"score_spread":0.17951081635550825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387387969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99317354,0.00023345195,0.000268831,0.00068731204,0.000039840772,0.00004835477,0.0011773244,0.000010523712,0.0043607024],"genre_scores_gemma":[0.9973538,0.00032483423,0.00011011959,0.000388038,0.000012835636,0.000013077442,0.0005136268,0.000005426819,0.0012781828],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99967706,0.000049262842,0.000039226838,0.000068447276,0.00004994551,0.00011605426],"domain_scores_gemma":[0.99943775,0.000068173395,0.00014806609,0.000035309524,0.00014177072,0.00016883443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031426921,0.0003885877,0.00029140312,0.0005195663,0.0006612338,0.0005964831,0.00032185786,0.0006878895,0.0044556963],"category_scores_gemma":[0.00091365207,0.00028789247,0.00032390986,0.0010337688,0.0004078481,0.0003995424,0.00040116007,0.0011127945,0.0007380444],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037053748,0.000112046335,0.9672495,0.00010587533,0.000056656663,0.009463959,0.0021711658,0.00025465112,0.007866865,0.0006467676,0.002614616,0.009087351],"study_design_scores_gemma":[0.000046269455,0.00037086004,0.9651472,0.000111276684,0.00006346537,0.00966132,0.015405902,0.00043499388,0.0009846517,0.0003350534,0.007384966,0.000053915297],"about_ca_topic_score_codex":0.050543077,"about_ca_topic_score_gemma":0.0352905,"teacher_disagreement_score":0.050543077,"about_ca_system_score_codex":0.0012420446,"about_ca_system_score_gemma":0.0011389804,"threshold_uncertainty_score":0.10049778},"labels":[],"label_agreement":null},{"id":"W4388741210","doi":"10.1016/j.biologicals.2023.101723","title":"Enabling the evaluation of COVID-19 vaccines with correlates of protection","year":2023,"lang":"en","type":"article","venue":"Biologicals","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Health Canada; U.S. Food and Drug Administration; University of Oxford; University of Washington; Imperial College London; Dartmouth College; California Institute of Technology; Emory University; Yale University; Coalition for Epidemic Preparedness Innovations; University of Pennsylvania; National Institutes of Health; London School of Hygiene and Tropical Medicine","keywords":"Coronavirus disease 2019 (COVID-19); Pandemic; Standardization; Vaccination; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Medicine; Alliance; Vaccine efficacy; Virology; Immunology; Computer science; Political science; Outbreak; Infectious disease (medical specialty); Disease","score_opus":0.22366448596766772,"score_gpt":0.4312918725802356,"score_spread":0.20762738661256788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388741210","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.36832082,0.39254048,0.120068595,0.033962246,0.0043430794,0.010031779,0.009494185,0.00056929485,0.06066956],"genre_scores_gemma":[0.8370925,0.055294316,0.08426668,0.0067305346,0.001714845,0.0050529684,0.005171854,0.00012528754,0.0045508775],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9575715,0.031409275,0.002586202,0.0013169023,0.0061904513,0.000925706],"domain_scores_gemma":[0.95146066,0.02073047,0.012383831,0.002901193,0.011332976,0.0011907795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.07569145,0.0010146875,0.0016008469,0.0020708968,0.0005126281,0.0024150363,0.0009823528,0.0010560965,0.00341995],"category_scores_gemma":[0.039858807,0.00046144528,0.0011323069,0.0021776636,0.0014987021,0.0021484953,0.0019853248,0.0025392964,0.00070129405],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011099234,0.0019574822,0.18093197,0.010393304,0.0014817357,0.0003064201,0.0008593632,0.0032880392,0.061888803,0.026535183,0.015350379,0.68590814],"study_design_scores_gemma":[0.0016036958,0.059039928,0.35899457,0.009079808,0.0030872172,0.001625668,0.0020093839,0.004629872,0.16883162,0.02760388,0.3632291,0.00026526686],"about_ca_topic_score_codex":0.0010067616,"about_ca_topic_score_gemma":0.0012153579,"teacher_disagreement_score":0.07569145,"about_ca_system_score_codex":0.0022312806,"about_ca_system_score_gemma":0.0040993025,"threshold_uncertainty_score":0.40029943},"labels":[],"label_agreement":null},{"id":"W4391781144","doi":"10.1016/j.biologicals.2024.101747","title":"Fourth Controlled Human Infection Model (CHIM) meeting – CHIMs in endemic countries, May 22–23, 2023","year":2024,"lang":"en","type":"article","venue":"Biologicals","topic":"Vaccine Coverage and Hesitancy","field":"Social Sciences","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Bill and Melinda Gates Foundation; European Commission; Medical Research Council; European Federation of Pharmaceutical Industries and Associations; Uganda National Council for Science and Technology; Wellcome Trust","keywords":"Incentive; Community engagement; Political science; Public relations; Economics","score_opus":0.04671254954478212,"score_gpt":0.3447865623980175,"score_spread":0.2980740128532354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391781144","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09800344,0.038120408,0.07157908,0.32173082,0.10208226,0.015031512,0.01919398,0.005096662,0.3291618],"genre_scores_gemma":[0.1431203,0.009440211,0.045806423,0.058868095,0.012594998,0.008266574,0.013689438,0.00095763826,0.7072563],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973374,0.0011369563,0.00008511344,0.0002506801,0.0006714084,0.00051846064],"domain_scores_gemma":[0.9967457,0.00045246034,0.0003507002,0.0002460005,0.00090484775,0.001300359],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013928132,0.001331819,0.0007017931,0.00075273536,0.002071499,0.0023379694,0.001773032,0.0047055893,0.026836492],"category_scores_gemma":[0.0036266446,0.0006574005,0.0011416243,0.00020912083,0.0014792848,0.0009481388,0.003215017,0.0044155265,0.0068142987],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030823748,0.00084187754,0.0027171555,0.00038525442,0.00009169551,0.0006727285,0.00025433328,0.0006273462,0.03008334,0.0054026474,0.9151487,0.04069255],"study_design_scores_gemma":[0.00026039843,0.0017678736,0.005469957,0.00022221691,0.000043829692,0.00019037878,0.00021594293,0.00076266273,0.007999664,0.0018270526,0.98118883,0.00005118896],"about_ca_topic_score_codex":0.0064765536,"about_ca_topic_score_gemma":0.01874712,"teacher_disagreement_score":0.026836492,"about_ca_system_score_codex":0.0026073558,"about_ca_system_score_gemma":0.0064130966,"threshold_uncertainty_score":0.08977699},"labels":[],"label_agreement":null},{"id":"W4392678954","doi":"10.1016/j.biologicals.2024.101756","title":"Maintaining the quality of vaccines through the use of standards: Current challenges and future opportunities","year":2024,"lang":"en","type":"article","venue":"Biologicals","topic":"Diphtheria, Corynebacterium, and Tetanus","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"World Health Organization","keywords":"Harmonization; Quality (philosophy); Business; Standardization; International standard; Human use; Best practice; Biotechnology; Good laboratory practice; Diversity (politics); Risk analysis (engineering); Engineering management; Quality assurance; Marketing; Engineering; Political science; Biology","score_opus":0.2280737115738715,"score_gpt":0.3680801841842667,"score_spread":0.1400064726103952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392678954","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012607242,0.23402472,0.06804969,0.6564364,0.007234944,0.00026191538,0.00030141414,0.0005042122,0.020579517],"genre_scores_gemma":[0.31559578,0.35803625,0.22107837,0.08198862,0.00836769,0.0008078957,0.0014262989,0.00042418943,0.012274937],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9647383,0.011788119,0.0037893767,0.002985963,0.013783803,0.0029145519],"domain_scores_gemma":[0.85610116,0.056412984,0.015085012,0.010183592,0.051432505,0.010784845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.11668786,0.001036565,0.0021584334,0.0016939791,0.0021871128,0.014564925,0.005829527,0.007871726,0.007324432],"category_scores_gemma":[0.06681617,0.00055534573,0.0007388583,0.0027005754,0.011109224,0.01864558,0.0059100245,0.009908686,0.0018711613],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036712261,0.00070721895,0.0051931,0.004073468,0.000090346955,0.00014180508,0.001332753,0.0023405217,0.00798345,0.280168,0.049147576,0.64845455],"study_design_scores_gemma":[0.00012734206,0.00077614596,0.0058826106,0.0058635897,0.00008175675,0.00045636317,0.006459682,0.0038831658,0.008480692,0.2764065,0.691323,0.00025918143],"about_ca_topic_score_codex":0.011225692,"about_ca_topic_score_gemma":0.007782347,"teacher_disagreement_score":0.11668786,"about_ca_system_score_codex":0.010027525,"about_ca_system_score_gemma":0.040055588,"threshold_uncertainty_score":0.61711174},"labels":[],"label_agreement":null},{"id":"W4403146384","doi":"10.1016/j.biologicals.2024.101794","title":"Assessment of the risks associated with the use of in vivo versus in vitro potency tests for vaccines","year":2024,"lang":"en","type":"editorial","venue":"Biologicals","topic":"Respiratory viral infections research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Health Canada","keywords":"Potency; In vivo; In vitro; Pharmacology; Chemistry; Medicine; Biology; Biotechnology; Biochemistry","score_opus":0.20292589142107495,"score_gpt":0.4622782736684853,"score_spread":0.2593523822474103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403146384","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007591567,0.008021762,0.00033551737,0.029289622,0.9607502,0.000033286015,0.000051299452,0.000047763348,0.0013946659],"genre_scores_gemma":[0.00072299753,0.0046855467,0.00028778028,0.027014092,0.96172136,0.00003768342,0.0000214099,0.000032065,0.005477011],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9857847,0.0042734346,0.001784786,0.0012698463,0.0063604647,0.0005266625],"domain_scores_gemma":[0.9185767,0.04839765,0.003460193,0.0017510353,0.023482602,0.0043318956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.026934922,0.0048470353,0.004574913,0.0037569054,0.0027017388,0.0081915585,0.005419289,0.02888251,0.0058647515],"category_scores_gemma":[0.055755787,0.0018086996,0.0035628444,0.0015765032,0.0041387547,0.004368527,0.0013487802,0.03015837,0.005527207],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018952168,0.000045754332,0.0000723516,0.0006431526,0.00009936825,0.00020328638,0.000026330466,0.00008118317,0.00023820341,0.001030735,0.9819664,0.015403642],"study_design_scores_gemma":[0.00020818447,0.0002199487,0.0007993098,0.0010162931,0.00028276225,0.00046617477,0.00007445989,0.0004772314,0.000599028,0.0029904994,0.99280965,0.00005644641],"about_ca_topic_score_codex":0.0017008877,"about_ca_topic_score_gemma":0.0040605445,"teacher_disagreement_score":0.02888251,"about_ca_system_score_codex":0.0038381654,"about_ca_system_score_gemma":0.0030836172,"threshold_uncertainty_score":0.14244717},"labels":[],"label_agreement":null},{"id":"W4403385257","doi":"10.1016/j.biologicals.2024.101796","title":"A vision for patient-centric specifications for biologicals","year":2024,"lang":"en","type":"editorial","venue":"Biologicals","topic":"Cell Image Analysis Techniques","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Medical physics; Computer science; Medicine","score_opus":0.022935851109291146,"score_gpt":0.32655556894667487,"score_spread":0.30361971783738373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403385257","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000031021485,0.0052376203,0.0011372528,0.16920272,0.82176554,0.000017258155,0.000037342837,0.000140973,0.0024302555],"genre_scores_gemma":[0.00095156283,0.0041362178,0.0009723904,0.15141164,0.8271628,0.00004589234,0.000052796728,0.00016459651,0.015102064],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9744329,0.0068345065,0.003537471,0.0020381557,0.011673844,0.0014831772],"domain_scores_gemma":[0.89936763,0.0482462,0.0039179814,0.0037128185,0.033424705,0.011330661],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.030919172,0.002820154,0.0026486483,0.003126881,0.0031988763,0.013721519,0.005401313,0.04426468,0.013185793],"category_scores_gemma":[0.07394724,0.0016686027,0.0031903395,0.0012781925,0.008686437,0.0084169,0.004800012,0.057068244,0.009143298],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012434733,0.0000075250555,0.000008649062,0.000079724225,0.000009201287,0.000065311724,0.000017239468,0.000029110102,0.000040576113,0.003819653,0.9912744,0.0046361964],"study_design_scores_gemma":[0.000027692022,0.000021309537,0.00005039705,0.00017072058,0.000016580067,0.00012530929,0.000028013263,0.00011669266,0.00007835989,0.0044615134,0.99488574,0.000017662858],"about_ca_topic_score_codex":0.0030474118,"about_ca_topic_score_gemma":0.0064166556,"teacher_disagreement_score":0.04426468,"about_ca_system_score_codex":0.00752149,"about_ca_system_score_gemma":0.009460589,"threshold_uncertainty_score":0.16351819},"labels":[],"label_agreement":null},{"id":"W4404659718","doi":"10.1016/j.biologicals.2024.101808","title":"The impact of LPS mutants on endotoxin masking in different detection systems","year":2024,"lang":"en","type":"article","venue":"Biologicals","topic":"Immune Response and Inflammation","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Advanced Micro Devices (Canada)","funders":"","keywords":"Masking (illustration); Mutant; Chemistry; Microbiology; Biology; Computational biology; Biochemistry; Gene","score_opus":0.01849848729144004,"score_gpt":0.2881980950023824,"score_spread":0.26969960771094237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404659718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965913,0.0004980908,0.002478219,0.000035439487,0.000013809557,0.000023674524,0.0000869088,0.00002163162,0.00025105436],"genre_scores_gemma":[0.9932841,0.00037618505,0.0055307117,0.000050953127,0.0000068210425,0.000023348985,0.0002005796,0.000017363345,0.0005098953],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99879384,0.00048520454,0.00012865238,0.00015203605,0.00032261477,0.00011753882],"domain_scores_gemma":[0.9991497,0.00031251024,0.00023505162,0.00009252209,0.00015191453,0.000058442725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007629869,0.00046926696,0.00033598038,0.00020009166,0.00012274385,0.00044364054,0.00017223407,0.00036951338,0.00032916557],"category_scores_gemma":[0.0011508391,0.00016177117,0.0002900245,0.00016121188,0.00023505333,0.00027073149,0.00027283293,0.00046025368,0.00015134469],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016474671,0.000029487892,0.0005585856,0.00003229719,0.000008268597,0.000015339358,0.000021863963,0.000069454785,0.99829084,0.000013222749,0.0000069095813,0.0007890704],"study_design_scores_gemma":[0.000003321247,0.0009218598,0.0035807437,0.0000056820404,0.000023396826,0.00009030277,0.000033616423,0.00049702846,0.99458957,0.000011693744,0.00023569031,0.000007186589],"about_ca_topic_score_codex":0.00052419526,"about_ca_topic_score_gemma":0.0005854414,"teacher_disagreement_score":0.0007629869,"about_ca_system_score_codex":0.00017326008,"about_ca_system_score_gemma":0.00015117624,"threshold_uncertainty_score":0.0040351152},"labels":[],"label_agreement":null},{"id":"W4405618609","doi":"10.1016/j.biologicals.2024.101778","title":"Integrating 3Rs approaches in WHO guidelines for the batch release testing of biologicals: Summary of NC3Rs final report to WHO Expert Committee for Biological Standardisation","year":2024,"lang":"en","type":"article","venue":"Biologicals","topic":"Respiratory viral infections research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"National Centre for the Replacement Refinement and Reduction of Animals in Research; National Centre for the Replacement, Refinement and Reduction of Animals in Research; Bill and Melinda Gates Foundation","keywords":"Biochemical engineering; Computer science; Engineering","score_opus":0.620108000662358,"score_gpt":0.5044749024143836,"score_spread":0.11563309824797441,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405618609","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010503647,0.09180917,0.21691039,0.27100295,0.036429975,0.04241201,0.03829316,0.006678292,0.28596044],"genre_scores_gemma":[0.031671844,0.099119805,0.42640737,0.14258693,0.007879382,0.03748249,0.050873842,0.0029601932,0.20101812],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.84550697,0.042055525,0.022119928,0.004765372,0.07915395,0.0063980957],"domain_scores_gemma":[0.75948876,0.04212818,0.018278683,0.010456721,0.16573586,0.0039119218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.1650857,0.0026386157,0.0022558759,0.008988873,0.0024682917,0.008369987,0.010778789,0.016655767,0.007017628],"category_scores_gemma":[0.11345349,0.0026952098,0.005324896,0.0052218693,0.0055128257,0.0039560087,0.0047655604,0.012167408,0.010760873],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029110708,0.00052741996,0.0025201233,0.00852883,0.00010898759,0.0011190767,0.002726989,0.0024223034,0.014264868,0.023518993,0.7990535,0.1449179],"study_design_scores_gemma":[0.00003923264,0.00024845122,0.0028236564,0.0044332882,0.00008593952,0.0002688466,0.00053551525,0.00029547673,0.004051071,0.0027452146,0.9843531,0.000120156896],"about_ca_topic_score_codex":0.057301328,"about_ca_topic_score_gemma":0.044832874,"teacher_disagreement_score":0.1650857,"about_ca_system_score_codex":0.009263749,"about_ca_system_score_gemma":0.06711176,"threshold_uncertainty_score":0.8730671},"labels":[],"label_agreement":null},{"id":"W4405651690","doi":"10.1016/j.biologicals.2024.101777","title":"Integrating 3Rs approaches in WHO guidelines for the batch release testing of biologicals: Reports from a series of NC3Rs stakeholder workshops","year":2024,"lang":"en","type":"article","venue":"Biologicals","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"Bill and Melinda Gates Foundation","keywords":"Stakeholder; Series (stratigraphy); Computer science; Information retrieval; Biology; Public relations; Political science","score_opus":0.6754634032037169,"score_gpt":0.4560452493986532,"score_spread":0.2194181538050637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405651690","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06163492,0.031388618,0.18251452,0.4532,0.008050805,0.023266478,0.004113435,0.001994111,0.23383713],"genre_scores_gemma":[0.34910658,0.0365515,0.40051877,0.0962843,0.002154815,0.021177722,0.0074139014,0.0021597815,0.08463255],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.7406661,0.14045656,0.02297339,0.0051241037,0.08126741,0.009512503],"domain_scores_gemma":[0.6961841,0.14996743,0.016535874,0.014894492,0.11471248,0.007705636],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.32102305,0.0017170543,0.001045583,0.0040244996,0.0039586006,0.0074389977,0.0080120545,0.009855978,0.0036403097],"category_scores_gemma":[0.1896329,0.0013352031,0.0022618875,0.003008761,0.0054742596,0.0048054704,0.013346908,0.010162298,0.0016205288],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061948283,0.001430752,0.007103954,0.013885851,0.00016969742,0.006457311,0.1776427,0.0042911405,0.0431601,0.062583484,0.28253406,0.40012142],"study_design_scores_gemma":[0.00006308676,0.00057925266,0.0058096778,0.0058448496,0.00008463327,0.000998544,0.027826969,0.0007672037,0.011822144,0.0090293065,0.93688375,0.00029064584],"about_ca_topic_score_codex":0.032390255,"about_ca_topic_score_gemma":0.042520788,"teacher_disagreement_score":0.32102305,"about_ca_system_score_codex":0.01514048,"about_ca_system_score_gemma":0.0688836,"threshold_uncertainty_score":0.83729947},"labels":[],"label_agreement":null},{"id":"W4408727992","doi":"10.1016/j.biologicals.2025.101821","title":"Global availability of critical reagents for biologicals testing - Current status, challenges and possible solutions","year":2025,"lang":"en","type":"article","venue":"Biologicals","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"Humane Society International","keywords":"Current (fluid); Biochemical engineering; Risk analysis (engineering); Computational biology; Data science; Biology; Medicine; Computer science; Engineering; Oceanography; Geology","score_opus":0.20636856003758755,"score_gpt":0.41314882603169506,"score_spread":0.2067802659941075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408727992","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029623702,0.2965488,0.038612366,0.5544374,0.0097459555,0.00035479636,0.0027329724,0.0020944758,0.06584952],"genre_scores_gemma":[0.36073118,0.42182666,0.073246166,0.09388884,0.008099522,0.00076807145,0.009751879,0.0012002542,0.030487448],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98638386,0.004262364,0.0011742408,0.0016888318,0.0045192596,0.001971433],"domain_scores_gemma":[0.9607117,0.016336832,0.005490847,0.0016185291,0.011455537,0.0043865195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.032476164,0.0012535129,0.0012630625,0.0026214684,0.0021222895,0.009992746,0.0040790443,0.0053671845,0.022863071],"category_scores_gemma":[0.022844154,0.0009437199,0.0013709161,0.0031849078,0.0040660906,0.016247168,0.007763823,0.007147298,0.0043600714],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005719527,0.00026535892,0.015785767,0.011979313,0.00009896438,0.0016237836,0.0037346575,0.004277113,0.012037213,0.08356777,0.18764655,0.6784116],"study_design_scores_gemma":[0.000031536067,0.00032610644,0.0070215957,0.005191332,0.00005752707,0.0010714361,0.0072494815,0.0014939656,0.004028771,0.045290645,0.9281103,0.00012718624],"about_ca_topic_score_codex":0.0076889647,"about_ca_topic_score_gemma":0.0068033934,"teacher_disagreement_score":0.032476164,"about_ca_system_score_codex":0.006098972,"about_ca_system_score_gemma":0.013740305,"threshold_uncertainty_score":0.17175245},"labels":[],"label_agreement":null},{"id":"W4408751013","doi":"10.1016/j.biologicals.2025.101826","title":"Multiple factors shape technology transfer for the development and manufacture of vaccines in Latin America and the Caribbean","year":2025,"lang":"en","type":"review","venue":"Biologicals","topic":"Innovation and Socioeconomic Development","field":"Business, Management and Accounting","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"EduCanada; World Health Organization","keywords":"Latin Americans; Technology transfer; Caribbean region; Virology; Biology; Political science; Business; International trade","score_opus":0.046554294992043097,"score_gpt":0.275252695328795,"score_spread":0.22869840033675187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408751013","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014903587,0.9902532,0.00012867914,0.002776987,0.000065509244,0.000012323316,0.000038017824,0.000003888709,0.0052311746],"genre_scores_gemma":[0.017504184,0.9814011,0.00028513707,0.0004268344,0.00004535821,0.000017580318,0.000025896385,0.0000024371884,0.00029154893],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.9981791,0.0008466544,0.00017264378,0.00016292049,0.00040847345,0.00023019248],"domain_scores_gemma":[0.9956174,0.002891813,0.00063625776,0.000076597615,0.0006670092,0.00011095753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039791847,0.00053688965,0.00071902265,0.0038491222,0.0007683816,0.0054899333,0.0009072324,0.0013703959,0.0034382069],"category_scores_gemma":[0.007939996,0.0002695321,0.00082278927,0.00760885,0.0014130938,0.0028244064,0.0012722918,0.0013590235,0.00026595933],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000100432626,0.00008410752,0.0057148435,0.073516496,0.00043312582,0.0006001494,0.003162422,0.001593728,0.0007084215,0.08892228,0.014430109,0.81073403],"study_design_scores_gemma":[0.00003122739,0.00007840958,0.017189283,0.07763938,0.000690532,0.00048586103,0.006343186,0.00042520132,0.00069123233,0.010025507,0.8863357,0.000064502514],"about_ca_topic_score_codex":0.05112885,"about_ca_topic_score_gemma":0.074543126,"teacher_disagreement_score":0.05112885,"about_ca_system_score_codex":0.005083118,"about_ca_system_score_gemma":0.015577409,"threshold_uncertainty_score":0.10166252},"labels":[],"label_agreement":null},{"id":"W4414163940","doi":"10.1016/j.biologicals.2025.101859","title":"Report of the fourth conference on next-generation sequencing (NGS) for adventitious virus detection in biologics for humans and animals: Validation and implementation of NGS","year":2025,"lang":"en","type":"article","venue":"Biologicals","topic":"Animal Virus Infections Studies","field":"Agricultural and Biological Sciences","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"World Health Organization","keywords":"Standardization; Food and drug administration; Guideline; Alliance; Harmonization; Key (lock)","score_opus":0.16485399598810574,"score_gpt":0.34340958759467777,"score_spread":0.17855559160657203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414163940","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04886435,0.06928553,0.1634325,0.21136162,0.19760744,0.015661104,0.013478061,0.0033037104,0.2770057],"genre_scores_gemma":[0.12608102,0.042329997,0.20229141,0.07768007,0.021641716,0.009814293,0.034586728,0.0030889923,0.4824858],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9712649,0.007899403,0.0011924467,0.0017149327,0.014367825,0.0035604604],"domain_scores_gemma":[0.9711492,0.0042499295,0.0013688848,0.0015691872,0.017410565,0.004252277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.041023005,0.0017761422,0.000783082,0.0018500772,0.0027155175,0.0069381227,0.0030392883,0.006713113,0.016622148],"category_scores_gemma":[0.018358368,0.0006621119,0.0022603807,0.0010106099,0.0013264322,0.0030756493,0.005393603,0.0075690844,0.009714754],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006731989,0.00060180365,0.0030145617,0.0023802782,0.00015249457,0.0009483655,0.0014356216,0.003553899,0.030106816,0.010980782,0.72761613,0.21853597],"study_design_scores_gemma":[0.000040024355,0.00031795815,0.0018721338,0.00043838803,0.00005453434,0.00013351139,0.00044291775,0.00046988123,0.016473325,0.0015722306,0.9780898,0.00009523674],"about_ca_topic_score_codex":0.011446605,"about_ca_topic_score_gemma":0.0130839,"teacher_disagreement_score":0.041023005,"about_ca_system_score_codex":0.005303806,"about_ca_system_score_gemma":0.023995133,"threshold_uncertainty_score":0.21695298},"labels":[],"label_agreement":null},{"id":"W4415103904","doi":"10.1016/j.biologicals.2025.101862","title":"Conference report WHO informal consultation on the draft WHO Guideline on the phasing out of animal tests for the quality control of biological products","year":2025,"lang":"en","type":"article","venue":"Biologicals","topic":"World Trade Organization Law","field":"Social Sciences","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Health Canada; Ministry of Public Health; National Institute of Food and Drug Safety Evaluation; National Centre for the Replacement, Refinement and Reduction of Animals in Research; U.S. Food and Drug Administration; National Institutes for Food and Drug Control; National Centre for the Replacement Refinement and Reduction of Animals in Research; Ministry of Food and Drug Safety; Agence Nationale de Sécurité du Médicament et des Produits de Santé; World Health Organization; Merck","keywords":"Guideline; Quality (philosophy); Control (management); Product (mathematics); Quality control; Protocol (science); Animal testing","score_opus":0.15803267520296815,"score_gpt":0.42003997461089715,"score_spread":0.262007299407929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415103904","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0051636114,0.006643985,0.012390986,0.5384193,0.03146657,0.0067010773,0.0055152713,0.0008420779,0.39285707],"genre_scores_gemma":[0.03069404,0.0043757525,0.012778679,0.35563213,0.0058866376,0.006552462,0.0036621972,0.0007316432,0.57968646],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.97218555,0.007630683,0.0019405594,0.0024310222,0.011353361,0.0044588107],"domain_scores_gemma":[0.96420825,0.0119323665,0.0011272224,0.0016615292,0.019182792,0.0018878639],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03845404,0.001232665,0.000877467,0.0019722474,0.005771845,0.0099325115,0.004221898,0.025484378,0.046449315],"category_scores_gemma":[0.047652606,0.00096986885,0.0019931442,0.0014687672,0.0026628203,0.005347568,0.0057350816,0.016429488,0.020905502],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037184094,0.0000807164,0.00023500623,0.00033174205,0.000010150424,0.00043710074,0.0014790525,0.00014990236,0.0015128185,0.021289257,0.96207356,0.0123635745],"study_design_scores_gemma":[0.000014254813,0.000022226277,0.00038827801,0.00033257497,0.000010594592,0.000053927164,0.00082734623,0.00007689488,0.0005991779,0.0023291935,0.99531794,0.000027739981],"about_ca_topic_score_codex":0.044200636,"about_ca_topic_score_gemma":0.03950742,"teacher_disagreement_score":0.046449315,"about_ca_system_score_codex":0.013809222,"about_ca_system_score_gemma":0.04795575,"threshold_uncertainty_score":0.20336682},"labels":[],"label_agreement":null},{"id":"W791093694","doi":"10.1016/j.biologicals.2015.05.013","title":"The regulation of cell therapy products in Canada","year":2015,"lang":"en","type":"article","venue":"Biologicals","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Canada","funders":"Health Canada","keywords":"Harmonization; Business; Transplantation; Regulatory authority; Product (mathematics); Risk analysis (engineering); Food and drug administration; Biotechnology; Medicine; Biology; Political science; Public administration","score_opus":0.08397976924490445,"score_gpt":0.28834345700202263,"score_spread":0.20436368775711816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W791093694","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18030712,0.02606031,0.0048734173,0.31357798,0.0023565295,0.00055006414,0.0017842811,0.00021633175,0.47027397],"genre_scores_gemma":[0.6722154,0.008878842,0.005481488,0.060401518,0.0003891892,0.00020300265,0.0003895843,0.00010017201,0.25194082],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9835803,0.0016731526,0.00046301997,0.001128944,0.008760336,0.004394291],"domain_scores_gemma":[0.97604364,0.0065309634,0.0012553388,0.00053244166,0.0109689925,0.0046686465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007886625,0.0003487226,0.00053068856,0.0020821195,0.01147249,0.009391814,0.0022851937,0.008331908,0.006254822],"category_scores_gemma":[0.017764624,0.0007868449,0.0008057983,0.0024717387,0.006345674,0.0013354942,0.0024890408,0.006648519,0.00044602784],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00021897256,0.0001694162,0.014410166,0.00031001976,0.00008334732,0.0011365858,0.0053450214,0.0029165843,0.0043049785,0.82129455,0.09992184,0.049888548],"study_design_scores_gemma":[0.000094028,0.00010918918,0.045083757,0.00048876315,0.00006962755,0.00020320607,0.0024810317,0.0027266245,0.0025994396,0.017351475,0.9285912,0.00020155973],"about_ca_topic_score_codex":0.9897495,"about_ca_topic_score_gemma":0.99225473,"teacher_disagreement_score":0.79866934,"about_ca_system_score_codex":0.20133063,"about_ca_system_score_gemma":0.3543749,"threshold_uncertainty_score":0.92634326},"labels":[],"label_agreement":null}]}